CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | spiro compound |
|
Accession: | CHEBI:33599
|
browse the term
|
Definition: | A compound having one atom as the only common member of two rings. |
Synonyms: | exact_synonym: | spiro compounds |
| related_synonym: | spiro-fused compounds; spirocycle; spirocycles; spirocyclic compound; spirocyclic compounds; spirofused compounds |
|
|
|
G |
Chrna4 |
cholinergic receptor, nicotinic, alpha polypeptide 4 |
multiple interactions |
ISO |
13-desmethylspirolide C binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein] |
CTD |
PMID:26063663 |
|
NCBI chr 2:181,022,311...181,043,579
Ensembl chr 2:181,018,380...181,043,546
|
|
G |
Chrna7 |
cholinergic receptor, nicotinic, alpha polypeptide 7 |
multiple interactions |
ISO |
13-desmethylspirolide C binds to and results in decreased activity of CHRNA7 protein |
CTD |
PMID:26063663 |
|
NCBI chr 7:63,098,692...63,212,526
Ensembl chr 7:63,098,692...63,212,569
|
|
G |
Chrnb2 |
cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal) |
multiple interactions |
ISO |
13-desmethylspirolide C binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein] |
CTD |
PMID:26063663 |
|
NCBI chr 3:89,753,448...89,764,632
Ensembl chr 3:89,746,195...89,764,632
|
|
|
G |
Abcc4 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
multiple interactions |
ISO |
Mefloquine inhibits the reaction [ABCC4 protein affects the export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; verlukast inhibits the reaction [ABCC4 protein affects the export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein] |
CTD |
PMID:16004972 |
|
NCBI chr14:118,482,692...118,707,856
Ensembl chr14:118,482,692...118,706,219
|
|
G |
Abcc5 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
increases export multiple interactions |
ISO |
ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein daidzein inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; hesperetin inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; naringenin inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; Quercetin inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; resveratrol inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; Silymarin inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; verlukast inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein] |
CTD |
PMID:16156793 |
|
NCBI chr16:20,331,303...20,426,428
Ensembl chr16:20,331,303...20,426,394
|
|
|
G |
Ncoa2 |
nuclear receptor coactivator 2 |
multiple interactions |
ISO |
22,23-dihydroavermectin B(1)a inhibits the reaction [Chenodeoxycholic Acid promotes the reaction [NR1H4 protein affects the localization of NCOA2 protein]] |
CTD |
PMID:25257666 |
|
NCBI chr 1:13,139,105...13,374,227
Ensembl chr 1:13,139,105...13,374,083
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
22,23-dihydroavermectin B(1)a inhibits the reaction [Chenodeoxycholic Acid promotes the reaction [NR1H4 protein affects the localization of NCOA2 protein]]; 22,23-dihydroavermectin B(1)a inhibits the reaction [Chenodeoxycholic Acid results in increased activity of NR1H4 protein]; 22,23-dihydroavermectin B(1)a inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] |
CTD |
PMID:25257666 |
|
NCBI chr10:89,454,234...89,533,645
Ensembl chr10:89,454,234...89,533,585
|
|
|
G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
affects transport multiple interactions increases export increases transport |
ISO |
ABCC2 protein affects the transport of 5(6)-carboxy-2',7'-dichlorofluorescein 4-hydroxy-2-nonenal inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein; Ascorbic Acid inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]]; Ascorbic Acid promotes the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; Atorvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Benzbromarone inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; Calcium deficiency inhibits the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein]; cyanoginosin LR inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; Cyclosporine inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; Fluvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Lovastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; microcystin RR inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; microcystin-LF inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; pitavastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Pravastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Probenecid inhibits the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein analog]; Rosuvastatin Calcium analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Simvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Tobacco Smoke Pollution inhibits the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein analog] ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein; ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein analog [ABCC2 gene mutant form results in increased expression of ABCC3 protein] which results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein; ABCC2 gene mutant form inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein; Atorvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Fluvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Fluvastatin promotes the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein]; Lovastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; pitavastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Pravastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Pravastatin promotes the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein]; Rosuvastatin Calcium analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Rosuvastatin Calcium promotes the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein]; Simvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein] |
CTD |
PMID:19326901 PMID:21240898 PMID:21341280 PMID:23562342 PMID:24907646 PMID:24909372 PMID:24973091 PMID:25862123 PMID:27450509 PMID:31348918 |
|
NCBI chr19:43,782,308...43,838,332
Ensembl chr19:43,782,192...43,840,740
|
|
G |
Abcc3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
multiple interactions increases transport |
ISO |
[ABCC2 gene mutant form results in increased expression of ABCC3 protein] which results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein Benzbromarone inhibits the reaction [ABCC3 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein] |
CTD |
PMID:24907646 PMID:31348918 |
|
NCBI chr11:94,343,295...94,393,017
Ensembl chr11:94,343,295...94,392,997
|
|
G |
Abcc5 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
multiple interactions increases transport |
ISO |
Benzbromarone inhibits the reaction [ABCC5 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein] |
CTD |
PMID:31348918 |
|
NCBI chr16:20,331,303...20,426,428
Ensembl chr16:20,331,303...20,426,394
|
|
|
G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
multiple interactions increases transport |
ISO |
quercetin 3'-sulfate inhibits the reaction [SLC22A8 protein results in increased transport of 4-carboxyfluorescein]; quercetin 3-O-glucuronide analog inhibits the reaction [SLC22A8 protein results in increased transport of 4-carboxyfluorescein]; quercetin 3-O-glucuronide inhibits the reaction [SLC22A8 protein results in increased transport of 4-carboxyfluorescein] |
CTD |
PMID:21244849 |
|
NCBI chr19:8,591,254...8,611,835
Ensembl chr19:8,591,254...8,611,835
|
|
|
G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
multiple interactions |
ISO |
ABCC2 protein affects the transport of [5-chloromethylfluorescein co-treated with Glutathione] |
CTD |
PMID:16049127 |
|
NCBI chr19:43,782,308...43,838,332
Ensembl chr19:43,782,192...43,840,740
|
|
|
G |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
increases export |
ISO |
ABCC1 protein results in increased export of 6-carboxyfluorescein |
CTD |
PMID:17940500 |
|
NCBI chr16:14,361,453...14,474,878
Ensembl chr16:14,361,558...14,475,737
|
|
G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
affects export multiple interactions |
ISO |
ABCC2 protein affects the export of 6-carboxyfluorescein Probenecid inhibits the reaction [ABCC2 protein affects the export of 6-carboxyfluorescein] |
CTD |
PMID:11477083 |
|
NCBI chr19:43,782,308...43,838,332
Ensembl chr19:43,782,192...43,840,740
|
|
G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
increases import multiple interactions |
ISO |
SLC22A6 protein results in increased import of 6-carboxyfluorescein 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [SLC22A6 protein results in increased import of 6-carboxyfluorescein]; glutaric acid promotes the reaction [SLC22A6 protein results in increased import of 6-carboxyfluorescein]; Probenecid inhibits the reaction [SLC22A6 protein results in increased import of 6-carboxyfluorescein] |
CTD |
PMID:28629854 |
|
NCBI chr19:8,617,996...8,628,299
Ensembl chr19:8,618,039...8,628,299
|
|
G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
increases import multiple interactions |
ISO |
SLC22A8 protein results in increased import of 6-carboxyfluorescein 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine promotes the reaction [2-amino-9H-pyrido(2,3-b)indole inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]]; 2-amino-9H-pyrido(2,3-b)indole inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; 2-amino-9H-pyrido(2,3-b)indole promotes the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]]; 3-amino-1-methyl-5H-pyrido(4,3-b)indole inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; Cadmium Chloride promotes the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; glutaric acid promotes the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; lead chloride promotes the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; Probenecid inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; sodium arsenate promotes the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein] |
CTD |
PMID:28629854 |
|
NCBI chr19:8,591,254...8,611,835
Ensembl chr19:8,591,254...8,611,835
|
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
increases expression |
ISO |
azaspiracid results in increased expression of ABCG2 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 6:58,584,491...58,692,451
Ensembl chr 6:58,584,523...58,695,676
|
|
G |
Adpgk |
ADP-dependent glucokinase |
increases expression |
ISO |
azaspiracid results in increased expression of ADPGK mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 9:59,291,572...59,316,200
Ensembl chr 9:59,291,558...59,324,052
|
|
G |
Afp |
alpha fetoprotein |
decreases expression |
ISO |
azaspiracid results in decreased expression of AFP mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 5:90,490,714...90,508,907
Ensembl chr 5:90,490,737...90,508,907
|
|
G |
Alb |
albumin |
decreases expression |
ISO |
azaspiracid results in decreased expression of ALB mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 5:90,460,870...90,476,602
Ensembl chr 5:90,460,897...90,476,602
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
decreases expression |
ISO |
azaspiracid results in decreased expression of ARNT mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 3:95,434,367...95,497,240
Ensembl chr 3:95,434,388...95,497,240
|
|
G |
B3gnt3 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
increases expression |
ISO |
azaspiracid results in increased expression of B3GNT3 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 8:71,691,373...71,702,626
Ensembl chr 8:71,690,756...71,701,789
|
|
G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
decreases expression |
ISO |
azaspiracid results in decreased expression of BCL2L11 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 2:128,126,038...128,162,547
Ensembl chr 2:128,126,038...128,162,547
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
increases expression |
ISO |
azaspiracid results in increased expression of BHLHE40 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 6:108,660,629...108,666,925
Ensembl chr 6:108,660,629...108,666,925
|
|
G |
Calu |
calumenin |
increases expression |
ISO |
azaspiracid results in increased expression of CALU mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 6:29,348,106...29,376,675
Ensembl chr 6:29,348,069...29,377,110
|
|
G |
Casp3 |
caspase 3 |
increases activity |
EXP |
azaspiracid results in increased activity of CASP3 protein |
CTD |
PMID:20047973 |
|
NCBI chr 8:46,617,291...46,639,698
Ensembl chr 8:46,617,291...46,639,689
|
|
G |
Cd44 |
CD44 antigen |
increases expression |
ISO |
azaspiracid results in increased expression of CD44 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 2:102,811,141...102,901,669
Ensembl chr 2:102,811,141...102,901,665
|
|
G |
Cdh1 |
cadherin 1 |
decreases uptake increases expression |
ISO |
azaspiracid results in decreased uptake of CDH1 protein modified form azaspiracid results in increased expression of CDH1 protein modified form |
CTD |
PMID:17118960 PMID:20547569 |
|
NCBI chr 8:106,603,350...106,670,247
Ensembl chr 8:106,603,351...106,670,246
|
|
G |
Ceacam1 |
carcinoembryonic antigen-related cell adhesion molecule 1 |
increases expression |
ISO |
azaspiracid results in increased expression of CEACAM1 mRNA |
CTD |
PMID:21853993 PMID:28939011 |
|
NCBI chr 7:25,461,702...25,477,647
Ensembl chr 7:25,461,707...25,477,603
|
|
G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
increases expression |
ISO |
azaspiracid results in increased expression of CEBPB mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 2:167,688,915...167,690,432
Ensembl chr 2:167,688,915...167,690,418
|
|
G |
Ctsd |
cathepsin D |
decreases metabolic processing |
ISO |
azaspiracid results in decreased metabolism of CTSD protein |
CTD |
PMID:23387425 |
|
NCBI chr 7:142,375,910...142,387,827
Ensembl chr 7:142,375,911...142,388,038
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
increases expression |
ISO |
azaspiracid results in increased expression of DDIT4 mRNA |
CTD |
PMID:21853993 PMID:28939011 |
|
NCBI chr10:59,949,675...59,951,770
Ensembl chr10:59,949,669...59,951,834
|
|
G |
Defb1 |
defensin beta 1 |
decreases expression |
ISO |
azaspiracid results in decreased expression of DEFB1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 8:21,776,555...21,795,185
Ensembl chr 8:21,776,599...21,795,185
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
increases expression |
ISO |
azaspiracid results in increased expression of DHCR7 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 7:143,823,167...143,848,410
Ensembl chr 7:143,823,145...143,848,410
|
|
G |
Dnajc10 |
DnaJ heat shock protein family (Hsp40) member C10 |
affects expression |
ISO |
azaspiracid affects the expression of DNAJC10 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 2:80,315,446...80,354,055
Ensembl chr 2:80,315,466...80,354,043
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
increases expression |
ISO |
azaspiracid results in increased expression of DUSP6 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr10:99,263,231...99,267,489
Ensembl chr10:99,263,231...99,267,489
|
|
G |
Edaradd |
EDAR (ectodysplasin-A receptor)-associated death domain |
increases expression |
ISO |
azaspiracid results in increased expression of EDARADD mRNA |
CTD |
PMID:28939011 |
|
NCBI chr13:12,471,209...12,520,535
Ensembl chr13:12,472,632...12,520,438
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
increases expression |
ISO |
azaspiracid results in increased expression of EGLN1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 8:124,908,587...124,949,254
Ensembl chr 8:124,908,587...124,949,324
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
increases expression |
ISO |
azaspiracid results in increased expression of EGLN3 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr12:54,178,981...54,203,874
Ensembl chr12:54,178,981...54,203,860
|
|
G |
Egr1 |
early growth response 1 |
increases expression |
ISO |
azaspiracid results in increased expression of EGR1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr18:34,861,207...34,864,956
Ensembl chr18:34,859,823...34,864,984
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases expression |
ISO |
azaspiracid results in increased expression of EIF2AK3 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 6:70,844,484...70,905,241
Ensembl chr 6:70,844,515...70,905,245
|
|
G |
Elovl6 |
ELOVL family member 6, elongation of long chain fatty acids (yeast) |
increases expression |
ISO |
azaspiracid results in increased expression of ELOVL6 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 3:129,532,386...129,638,495
Ensembl chr 3:129,532,355...129,638,495
|
|
G |
Emp1 |
epithelial membrane protein 1 |
increases expression |
ISO |
azaspiracid results in increased expression of EMP1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 6:135,362,550...135,383,173
Ensembl chr 6:135,362,545...135,383,173
|
|
G |
Eno1 |
enolase 1, alpha non-neuron |
increases expression |
ISO |
azaspiracid results in increased expression of ENO1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 4:150,236,708...150,248,879
Ensembl chr 4:150,236,721...150,248,879
|
|
G |
Eno2 |
enolase 2, gamma neuronal |
increases expression |
ISO |
azaspiracid results in increased expression of ENO2 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 6:124,760,053...124,769,673
Ensembl chr 6:124,760,053...124,769,673
|
|
G |
Ern1 |
endoplasmic reticulum (ER) to nucleus signalling 1 |
decreases expression |
ISO |
azaspiracid results in decreased expression of ERN1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr11:106,397,620...106,487,796
Ensembl chr11:106,394,650...106,487,852
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
increases expression |
ISO |
azaspiracid results in increased expression of FDFT1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr14:63,145,150...63,181,687
Ensembl chr14:63,145,150...63,179,578
|
|
G |
Fdps |
farnesyl diphosphate synthetase |
increases expression |
ISO |
azaspiracid results in increased expression of FDPS mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 3:89,093,588...89,101,967
Ensembl chr 3:89,093,588...89,101,959
|
|
G |
Fga |
fibrinogen alpha chain |
decreases expression |
ISO |
azaspiracid results in decreased expression of FGA mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 3:83,026,153...83,033,627
Ensembl chr 3:83,026,076...83,033,627
|
|
G |
Fgb |
fibrinogen beta chain |
decreases expression |
ISO |
azaspiracid results in decreased expression of FGB mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 3:83,042,246...83,049,863
Ensembl chr 3:83,040,141...83,049,863
|
|
G |
Fgg |
fibrinogen gamma chain |
decreases expression |
ISO |
azaspiracid results in decreased expression of FGG mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 3:83,007,724...83,015,056
Ensembl chr 3:83,007,724...83,015,049
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
increases expression |
ISO |
azaspiracid results in increased expression of FOS mRNA |
CTD |
PMID:28939011 |
|
NCBI chr12:85,473,890...85,477,274
Ensembl chr12:85,473,890...85,477,273
|
|
G |
Gm40318 |
predicted gene, 40318 |
increases expression |
ISO |
azaspiracid results in increased expression of S100P mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 5:36,762,504...36,767,419
Ensembl chr 5:36,762,617...36,766,695
|
|
G |
Gpc5 |
glypican 5 |
decreases expression |
ISO |
azaspiracid results in decreased expression of GPC5 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr14:115,092,201...116,525,192
Ensembl chr14:115,092,215...116,525,179
|
|
G |
Gpi1 |
glucose-6-phosphate isomerase 1 |
affects expression |
ISO |
azaspiracid affects the expression of GPI mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 7:34,201,327...34,230,336
Ensembl chr 7:34,201,330...34,230,336
|
|
G |
Gsta1 |
glutathione S-transferase, alpha 1 (Ya) |
decreases expression |
ISO |
azaspiracid results in decreased expression of GSTA5 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 9:78,230,669...78,242,683
Ensembl chr 9:78,230,656...78,242,684
|
|
G |
Gsta3 |
glutathione S-transferase, alpha 3 |
decreases expression |
ISO |
azaspiracid results in decreased expression of GSTA3 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 1:21,240,565...21,265,575
Ensembl chr 1:21,240,589...21,265,661
|
|
G |
H1f4 |
H1.4 linker histone, cluster member |
decreases expression |
ISO |
azaspiracid results in decreased expression of H1-4 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr13:23,621,777...23,622,558
Ensembl chr13:23,620,629...23,622,558
|
|
G |
H4c3 |
H4 clustered histone 3 |
decreases expression |
ISO |
azaspiracid results in decreased expression of H4C3 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr13:23,698,084...23,698,458
Ensembl chr13:23,697,635...23,698,454
|
|
G |
Hif1a |
hypoxia inducible factor 1, alpha subunit |
decreases expression |
ISO |
azaspiracid results in decreased expression of HIF1A mRNA |
CTD |
PMID:28939011 |
|
NCBI chr12:73,901,324...73,947,554
Ensembl chr12:73,901,375...73,947,530
|
|
G |
Hk2 |
hexokinase 2 |
increases expression |
ISO |
azaspiracid results in increased expression of HK2 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 6:82,725,025...82,774,454
Ensembl chr 6:82,725,025...82,774,454
|
|
G |
Hkdc1 |
hexokinase domain containing 1 |
increases expression |
ISO |
azaspiracid results in increased expression of HKDC1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr10:62,383,137...62,423,711
Ensembl chr10:62,383,137...62,422,491
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
increases expression |
ISO |
azaspiracid results in increased expression of HMGCR mRNA |
CTD |
PMID:28939011 |
|
NCBI chr13:96,648,962...96,670,936
Ensembl chr13:96,648,967...96,670,936
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 |
increases expression |
ISO |
azaspiracid results in increased expression of HMGCS1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr13:119,690,351...119,708,260
Ensembl chr13:119,690,379...119,708,260
|
|
G |
Hoxb6 |
homeobox B6 |
increases expression |
ISO |
azaspiracid results in increased expression of HOXB6 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr11:96,292,814...96,301,569
Ensembl chr11:96,292,476...96,301,569
|
|
G |
Hoxb9 |
homeobox B9 |
increases expression |
ISO |
azaspiracid results in increased expression of HOXB9 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr11:96,271,330...96,276,595
Ensembl chr11:96,271,457...96,276,595
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase |
increases expression |
ISO |
azaspiracid results in increased expression of IDI1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr13:8,885,606...8,892,396
Ensembl chr13:8,885,501...8,892,451
|
|
G |
Jun |
jun proto-oncogene |
increases expression |
ISO |
azaspiracid results in increased expression of JUN mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 4:95,049,036...95,052,222
Ensembl chr 4:95,049,034...95,052,222
|
|
G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
multiple interactions |
ISO |
azaspiracid binds to and results in decreased activity of KCNH2 protein |
CTD |
PMID:22856456 |
|
NCBI chr 5:24,319,589...24,351,684
Ensembl chr 5:24,319,589...24,351,604
|
|
G |
Lama1 |
laminin, alpha 1 |
decreases expression |
ISO |
azaspiracid results in decreased expression of LAMA1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr17:67,697,127...67,822,645
Ensembl chr17:67,697,259...67,822,647
|
|
G |
Ldlr |
low density lipoprotein receptor |
increases expression |
ISO |
azaspiracid results in increased expression of LDLR mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 9:21,723,576...21,749,919
Ensembl chr 9:21,723,483...21,749,919
|
|
G |
Lmnb1 |
lamin B1 |
decreases expression |
ISO |
azaspiracid results in decreased expression of LMNB1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr18:56,707,813...56,753,424
Ensembl chr18:56,707,813...56,753,424
|
|
G |
Lpin1 |
lipin 1 |
increases expression |
ISO |
azaspiracid results in increased expression of LPIN1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr12:16,535,669...16,653,903
Ensembl chr12:16,535,669...16,646,966
|
|
G |
Map2k3 |
mitogen-activated protein kinase kinase 3 |
decreases expression |
ISO |
azaspiracid results in decreased expression of MAP2K3 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr11:60,932,054...60,952,811
Ensembl chr11:60,932,033...60,952,811
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
EXP |
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [azaspiracid results in increased phosphorylation of and affects the localization of MAPK8 protein]; Amiloride inhibits the reaction [azaspiracid results in increased phosphorylation of and affects the localization of MAPK8 protein]; azaspiracid results in increased phosphorylation of and affects the localization of MAPK8 protein |
CTD |
PMID:19815690 |
|
NCBI chr14:33,377,898...33,447,353
Ensembl chr14:33,377,898...33,447,158
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions |
EXP |
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [azaspiracid results in increased phosphorylation of and affects the localization of MAPK9 protein]; Amiloride inhibits the reaction [azaspiracid results in increased phosphorylation of and affects the localization of MAPK9 protein]; azaspiracid results in increased phosphorylation of and affects the localization of MAPK9 protein |
CTD |
PMID:19815690 |
|
NCBI chr11:49,846,728...49,886,421
Ensembl chr11:49,846,751...49,886,421
|
|
G |
Mgst1 |
microsomal glutathione S-transferase 1 |
increases expression |
ISO |
azaspiracid results in increased expression of MGST1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 6:138,140,527...138,156,755
Ensembl chr 6:138,140,316...138,156,755
|
|
G |
Mgst2 |
microsomal glutathione S-transferase 2 |
increases expression |
ISO |
azaspiracid results in increased expression of MGST2 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 3:51,636,912...51,682,675
Ensembl chr 3:51,660,360...51,682,677
|
|
G |
Mmp1b |
matrix metallopeptidase 1b (interstitial collagenase) |
increases expression |
ISO |
azaspiracid results in increased expression of MMP1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 9:7,367,670...7,388,026
Ensembl chr 9:7,368,239...7,388,047
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
ISO |
azaspiracid results in increased expression of MT1X mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 8:94,178,883...94,180,327
Ensembl chr 8:94,179,082...94,180,327
|
|
G |
Mt2 |
metallothionein 2 |
increases expression |
ISO |
azaspiracid results in increased expression of MT2A mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 8:94,172,618...94,173,567
Ensembl chr 8:94,172,664...94,173,568
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase |
increases expression |
ISO |
azaspiracid results in increased expression of MTHFD2 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 6:83,305,704...83,326,011
Ensembl chr 6:83,305,691...83,325,908
|
|
G |
Mvk |
mevalonate kinase |
increases expression |
ISO |
azaspiracid results in increased expression of MVK mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 5:114,444,264...114,460,591
Ensembl chr 5:114,444,269...114,460,591
|
|
G |
Myc |
myelocytomatosis oncogene |
increases expression |
ISO |
azaspiracid results in increased expression of MYC mRNA |
CTD |
PMID:28939011 |
|
NCBI chr15:61,985,341...61,990,361
Ensembl chr15:61,985,391...61,990,374
|
|
G |
Osr2 |
odd-skipped related 2 |
decreases expression |
ISO |
azaspiracid results in decreased expression of OSR2 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr15:35,296,098...35,303,305
Ensembl chr15:35,296,098...35,303,305
|
|
G |
Pdhb |
pyruvate dehydrogenase (lipoamide) beta |
increases expression |
ISO |
azaspiracid results in increased expression of PDHB mRNA |
CTD |
PMID:28939011 |
|
NCBI chr14:8,165,991...8,173,303
Ensembl chr14:8,165,996...8,173,025
|
|
G |
Pdia3 |
protein disulfide isomerase associated 3 |
increases expression |
ISO |
azaspiracid results in increased expression of PDIA3 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 2:121,413,902...121,438,687
Ensembl chr 2:121,413,775...121,438,687
|
|
G |
Pfkp |
phosphofructokinase, platelet |
increases expression |
ISO |
azaspiracid results in increased expression of PFKP mRNA |
CTD |
PMID:28939011 |
|
NCBI chr13:6,579,874...6,649,060
Ensembl chr13:6,579,768...6,648,777
|
|
G |
Pgam1 |
phosphoglycerate mutase 1 |
increases expression |
ISO |
azaspiracid results in increased expression of PGAM1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr19:41,911,871...41,918,665
Ensembl chr19:41,911,923...41,918,660
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
increases expression |
ISO |
azaspiracid results in increased expression of PGK1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr X:106,187,100...106,203,699
Ensembl chr X:106,187,100...106,203,699
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
increases expression |
ISO |
azaspiracid results in increased expression of PPP1R15A mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 7:45,522,917...45,526,268
Ensembl chr 7:45,522,916...45,526,268
|
|
G |
Prlr |
prolactin receptor |
decreases uptake |
ISO |
azaspiracid results in decreased uptake of PRLR protein |
CTD |
PMID:20547569 |
|
NCBI chr15:10,177,238...10,349,190
Ensembl chr15:10,177,238...10,349,180
|
|
G |
Rps27a |
ribosomal protein S27A |
increases expression |
ISO |
azaspiracid results in increased expression of RPS27A mRNA |
CTD |
PMID:28939011 |
|
NCBI chr11:29,545,842...29,548,040
Ensembl chr11:29,545,846...29,548,109
|
|
G |
Scd2 |
stearoyl-Coenzyme A desaturase 2 |
increases expression |
ISO |
azaspiracid results in increased expression of SCD mRNA |
CTD |
PMID:28939011 |
|
NCBI chr19:44,293,676...44,306,864
Ensembl chr19:44,293,674...44,306,864
|
|
G |
Sis |
sucrase isomaltase (alpha-glucosidase) |
decreases expression |
ISO |
azaspiracid results in decreased expression of SI mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 3:72,888,557...72,967,863
Ensembl chr 3:72,888,557...72,967,863
|
|
G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
increases expression |
ISO |
azaspiracid results in increased expression of SLC2A1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 4:119,108,745...119,137,330
Ensembl chr 4:119,108,711...119,137,983
|
|
G |
Slc7a11 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 |
increases expression |
ISO |
azaspiracid results in increased expression of SLC7A11 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 3:50,364,936...50,499,087
Ensembl chr 3:49,892,526...50,443,614
|
|
G |
Sptlc3 |
serine palmitoyltransferase, long chain base subunit 3 |
decreases expression |
ISO |
azaspiracid results in decreased expression of SPTLC3 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 2:139,493,913...139,637,061
Ensembl chr 2:139,493,913...139,637,674
|
|
G |
Sptssb |
serine palmitoyltransferase, small subunit B |
decreases expression |
ISO |
azaspiracid results in decreased expression of SPTSSB mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 3:69,819,538...69,861,363
Ensembl chr 3:69,819,542...69,859,940
|
|
G |
Sqle |
squalene epoxidase |
increases expression |
ISO |
azaspiracid results in increased expression of SQLE mRNA |
CTD |
PMID:28939011 |
|
NCBI chr15:59,315,092...59,331,193
Ensembl chr15:59,315,077...59,331,192
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
increases expression |
ISO |
azaspiracid results in increased expression of SREBF1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr11:60,199,084...60,224,186
Ensembl chr11:60,199,089...60,222,581
|
|
G |
Stard4 |
StAR-related lipid transfer (START) domain containing 4 |
increases expression |
ISO |
azaspiracid results in increased expression of STARD4 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr18:33,199,138...33,213,862
Ensembl chr18:33,199,355...33,213,862
|
|
G |
Timp1 |
tissue inhibitor of metalloproteinase 1 |
increases expression |
ISO |
azaspiracid results in increased expression of TIMP1 protein |
CTD |
PMID:26865666 |
|
NCBI chr X:20,870,166...20,874,737
Ensembl chr X:20,870,166...20,874,735
|
|
G |
Tns4 |
tensin 4 |
increases expression |
ISO |
azaspiracid results in increased expression of TNS4 mRNA |
CTD |
PMID:21853993 |
|
NCBI chr11:99,065,678...99,089,306
Ensembl chr11:99,065,678...99,089,306
|
|
G |
Tpi1 |
triosephosphate isomerase 1 |
increases expression |
ISO |
azaspiracid results in increased expression of TPI1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 6:124,810,586...124,814,158
Ensembl chr 6:124,810,586...124,814,296
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
increases expression |
ISO |
azaspiracid results in increased expression of TRIB3 mRNA |
CTD |
PMID:21853993 PMID:28939011 |
|
NCBI chr 2:152,337,425...152,344,060
Ensembl chr 2:152,337,422...152,344,032
|
|
G |
Tubb3 |
tubulin, beta 3 class III |
increases expression |
ISO |
azaspiracid results in increased expression of TUBB3 mRNA |
CTD |
PMID:21853993 |
|
NCBI chr 8:123,411,553...123,422,015
Ensembl chr 8:123,411,424...123,422,015
|
|
G |
Ubb |
ubiquitin B |
increases expression |
ISO |
azaspiracid results in increased expression of UBB mRNA |
CTD |
PMID:28939011 |
|
NCBI chr11:62,551,171...62,553,213
Ensembl chr11:62,551,171...62,553,213
|
|
G |
Ubc |
ubiquitin C |
increases expression |
ISO |
azaspiracid results in increased expression of UBC mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 5:125,385,965...125,390,017
Ensembl chr 5:125,385,965...125,390,202
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression |
ISO |
azaspiracid results in increased expression of VEGFA mRNA |
CTD |
PMID:28939011 |
|
NCBI chr17:46,016,993...46,032,377
Ensembl chr17:46,016,993...46,032,369
|
|
|
G |
1810010H24Rik |
RIKEN cDNA 1810010H24 gene |
increases expression |
ISO |
Buspirone results in increased expression of RGD1565033 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:107,023,269...107,030,443
Ensembl chr11:107,025,681...107,030,443
|
|
G |
2300009A05Rik |
RIKEN cDNA 2300009A05 gene |
increases expression |
ISO |
Buspirone results in increased expression of RGD1309779 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:63,394,447...63,399,244
Ensembl chr 9:63,394,447...63,399,246
|
|
G |
4930550C14Rik |
RIKEN cDNA 4930550C14 gene |
increases expression |
ISO |
Buspirone results in increased expression of RGD1311251 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:53,402,713...53,434,426
Ensembl chr 9:53,402,325...53,434,402
|
|
G |
4931406C07Rik |
RIKEN cDNA 4931406C07 gene |
decreases expression |
ISO |
Buspirone results in decreased expression of RGD1309534 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:15,283,337...15,306,448
Ensembl chr 9:15,283,337...15,306,448
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
increases expression |
ISO |
Buspirone results in increased expression of AASS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:23,072,173...23,132,986
Ensembl chr 6:23,072,173...23,132,986
|
|
G |
Abca1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
increases expression |
ISO |
Buspirone results in increased expression of ABCA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895
|
|
G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of ABCC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:43,782,308...43,838,332
Ensembl chr19:43,782,192...43,840,740
|
|
G |
Abcf1 |
ATP-binding cassette, sub-family F (GCN20), member 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of ABCF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:35,956,819...35,969,750
Ensembl chr17:35,956,819...35,969,761
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
decreases expression |
ISO |
Buspirone results in decreased expression of ABCG2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:58,584,491...58,692,451
Ensembl chr 6:58,584,523...58,695,676
|
|
G |
Abhd14b |
abhydrolase domain containing 14b |
increases expression |
ISO |
Buspirone results in increased expression of ABHD14B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:106,447,737...106,452,923
Ensembl chr 9:106,447,459...106,452,923
|
|
G |
Abtb1 |
ankyrin repeat and BTB (POZ) domain containing 1 |
increases expression |
ISO |
Buspirone results in increased expression of ABTB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:88,835,914...88,842,375
Ensembl chr 6:88,835,914...88,841,984
|
|
G |
Acaa2 |
acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase) |
increases expression |
ISO |
Buspirone results in increased expression of ACAA2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:74,779,212...74,806,207
Ensembl chr18:74,779,197...74,806,208
|
|
G |
Acaca |
acetyl-Coenzyme A carboxylase alpha |
decreases expression |
ISO |
Buspirone results in decreased expression of ACACA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:84,129,635...84,401,651
Ensembl chr11:84,129,672...84,401,651
|
|
G |
Acbd4 |
acyl-Coenzyme A binding domain containing 4 |
increases expression |
ISO |
Buspirone results in increased expression of ACBD4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:103,101,688...103,112,199
Ensembl chr11:103,101,682...103,112,200
|
|
G |
Acly |
ATP citrate lyase |
decreases expression |
ISO |
Buspirone results in decreased expression of ACLY mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:100,476,352...100,528,000
Ensembl chr11:100,476,353...100,528,000
|
|
G |
Acsf2 |
acyl-CoA synthetase family member 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of ACSF2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:94,557,102...94,602,139
Ensembl chr11:94,557,102...94,601,871
|
|
G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
decreases expression |
ISO |
Buspirone results in decreased expression of ACSL3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:78,657,825...78,707,743
Ensembl chr 1:78,657,825...78,707,743
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
increases expression |
ISO |
Buspirone results in increased expression of ACSL4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:142,317,993...142,390,802
Ensembl chr X:142,317,993...142,390,535
|
|
G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
decreases expression |
ISO |
Buspirone results in decreased expression of ACSL5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:55,251,861...55,296,628
Ensembl chr19:55,251,938...55,297,720
|
|
G |
Actb |
actin, beta |
decreases expression |
ISO |
Buspirone results in decreased expression of ACTB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:142,903,115...142,907,976
Ensembl chr 5:142,903,115...142,906,754
|
|
G |
Actg1 |
actin, gamma, cytoplasmic 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of ACTG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:120,345,687...120,348,495
Ensembl chr11:120,345,690...120,348,542
|
|
G |
Actn1 |
actinin, alpha 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of ACTN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:80,167,542...80,260,420
Ensembl chr12:80,167,547...80,260,371
|
|
G |
Acy1 |
aminoacylase 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of ACY1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:106,432,981...106,438,236
Ensembl chr 9:106,432,981...106,438,319
|
|
G |
Adamtsl4 |
ADAMTS-like 4 |
increases expression |
ISO |
Buspirone results in increased expression of ADAMTSL4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:95,676,201...95,687,927
Ensembl chr 3:95,676,201...95,687,917
|
|
G |
Adcy6 |
adenylate cyclase 6 |
increases expression |
ISO |
Buspirone results in increased expression of ADCY6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:98,589,978...98,610,287
Ensembl chr15:98,589,973...98,610,076
|
|
G |
Adipor2 |
adiponectin receptor 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of ADIPOR2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:119,353,150...119,417,699
Ensembl chr 6:119,353,150...119,417,704
|
|
G |
Adra1a |
adrenergic receptor, alpha 1a |
multiple interactions |
ISO |
Buspirone binds to and results in decreased activity of ADRA1A protein |
CTD |
PMID:16545797 |
|
NCBI chr14:66,635,251...66,771,240
Ensembl chr14:66,635,251...66,771,168
|
|
G |
Adra1d |
adrenergic receptor, alpha 1d |
multiple interactions |
ISO |
Buspirone binds to and results in increased activity of ADRA1D protein |
CTD |
PMID:15872040 |
|
NCBI chr 2:131,545,357...131,562,497
Ensembl chr 2:131,545,850...131,562,283
|
|
G |
Agmat |
agmatine ureohydrolase (agmatinase) |
increases expression |
ISO |
Buspirone results in increased expression of AGMAT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:141,746,675...141,759,263
Ensembl chr 4:141,746,672...141,759,263
|
|
G |
Ahcy |
S-adenosylhomocysteine hydrolase |
increases expression |
ISO |
Buspirone results in increased expression of AHCY mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:155,059,310...155,074,497
Ensembl chr 2:155,059,310...155,074,497
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of AIF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:35,170,986...35,176,083
Ensembl chr17:35,170,991...35,176,068
|
|
G |
Aig1 |
androgen-induced 1 |
increases expression |
ISO |
Buspirone results in increased expression of AIG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:13,647,054...13,869,038
Ensembl chr10:13,647,054...13,868,980
|
|
G |
Ak4 |
adenylate kinase 4 |
decreases expression |
ISO |
Buspirone results in decreased expression of AK4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:101,416,478...101,467,771
Ensembl chr 4:101,419,277...101,466,995
|
|
G |
Akap8l |
A kinase (PRKA) anchor protein 8-like |
increases expression |
ISO |
Buspirone results in increased expression of AKAP8L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:32,321,424...32,350,616
Ensembl chr17:32,321,424...32,350,607
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
decreases expression |
ISO |
Buspirone results in decreased expression of ALDH1B1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:45,799,022...45,804,608
Ensembl chr 4:45,799,022...45,804,604
|
|
G |
Alkbh7 |
alkB homolog 7 |
increases expression |
ISO |
Buspirone results in increased expression of ALKBH7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:56,997,339...56,999,340
Ensembl chr17:56,997,339...56,999,322
|
|
G |
Ank |
progressive ankylosis |
decreases expression |
ISO |
Buspirone results in decreased expression of ANKH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:27,466,677...27,594,909
Ensembl chr15:27,466,677...27,594,909
|
|
G |
Ankrd46 |
ankyrin repeat domain 46 |
increases expression |
ISO |
Buspirone results in increased expression of ANKRD46 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:36,477,668...36,496,791
Ensembl chr15:36,477,668...36,496,820
|
|
G |
Antxr2 |
anthrax toxin receptor 2 |
increases expression |
ISO |
Buspirone results in increased expression of ANTXR2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:97,884,688...98,031,017
Ensembl chr 5:97,882,783...98,031,043
|
|
G |
Anxa3 |
annexin A3 |
decreases expression |
ISO |
Buspirone results in decreased expression of ANXA3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:96,793,385...96,845,968
Ensembl chr 5:96,793,339...96,845,966
|
|
G |
Anxa5 |
annexin A5 |
decreases expression |
ISO |
Buspirone results in decreased expression of ANXA5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:36,448,923...36,475,887
Ensembl chr 3:36,448,923...36,475,894
|
|
G |
Apob |
apolipoprotein B |
decreases expression |
ISO |
Buspirone results in decreased expression of APOB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:7,977,629...8,016,839
Ensembl chr12:7,977,648...8,016,835
|
|
G |
Apoo |
apolipoprotein O |
decreases expression |
ISO |
Buspirone results in decreased expression of APOO mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:94,367,010...94,417,093
Ensembl chr X:94,367,117...94,417,093
|
|
G |
Apool |
apolipoprotein O-like |
decreases expression |
ISO |
Buspirone results in decreased expression of APOOL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:112,311,352...112,372,755
Ensembl chr X:112,311,334...112,372,755
|
|
G |
App |
amyloid beta (A4) precursor protein |
decreases expression |
ISO |
Buspirone results in decreased expression of APP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:84,952,666...85,175,255
Ensembl chr16:84,949,685...85,173,766
|
|
G |
Arhgap24 |
Rho GTPase activating protein 24 |
decreases expression |
ISO |
Buspirone results in decreased expression of ARHGAP24 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:102,207,198...102,905,035
Ensembl chr 5:102,481,391...102,897,937
|
|
G |
Arhgdib |
Rho, GDP dissociation inhibitor (GDI) beta |
decreases expression |
ISO |
Buspirone results in decreased expression of ARHGDIB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:136,923,655...136,941,899
Ensembl chr 6:136,923,655...136,941,899
|
|
G |
Arl1 |
ADP-ribosylation factor-like 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of ARL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:88,730,920...88,744,094
Ensembl chr10:88,730,858...88,744,094
|
|
G |
Arl4a |
ADP-ribosylation factor-like 4A |
increases expression |
ISO |
Buspirone results in increased expression of ARL4A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:40,033,291...40,037,987
Ensembl chr12:40,005,447...40,038,025
|
|
G |
Arl6ip1 |
ADP-ribosylation factor-like 6 interacting protein 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of ARL6IP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:118,118,890...118,129,625
Ensembl chr 7:118,118,891...118,129,662
|
|
G |
Armt1 |
acidic residue methyltransferase 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of ARMT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:4,429,275...4,455,140
Ensembl chr10:4,432,467...4,455,141
|
|
G |
Arsb |
arylsulfatase B |
decreases expression |
ISO |
Buspirone results in decreased expression of ARSB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:93,771,679...93,943,016
Ensembl chr13:93,771,630...93,943,016
|
|
G |
As3mt |
arsenite methyltransferase |
increases expression |
ISO |
Buspirone results in increased expression of AS3MT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:46,707,157...46,741,099
Ensembl chr19:46,707,458...46,741,099
|
|
G |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of ASAP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:21,111,368...21,270,171
Ensembl chr12:20,990,459...21,270,171
|
|
G |
Asgr1 |
asialoglycoprotein receptor 1 |
increases expression |
ISO |
Buspirone results in increased expression of ASGR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:70,048,909...70,057,895
Ensembl chr11:70,054,085...70,057,894
|
|
G |
Aspg |
asparaginase |
increases expression |
ISO |
Buspirone results in increased expression of ASPG mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:112,106,683...112,127,573
Ensembl chr12:112,106,679...112,127,559
|
|
G |
Atf5 |
activating transcription factor 5 |
increases expression |
ISO |
Buspirone results in increased expression of ATF5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:44,812,256...44,816,658
Ensembl chr 7:44,812,256...44,816,658
|
|
G |
Atg2b |
autophagy related 2B |
increases expression |
ISO |
Buspirone results in increased expression of ATG2B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:105,613,539...105,685,297
Ensembl chr12:105,616,136...105,685,211
|
|
G |
Atl2 |
atlastin GTPase 2 |
increases expression |
ISO |
Buspirone results in increased expression of ATL2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:79,848,352...79,896,204
Ensembl chr17:79,848,390...79,896,123
|
|
G |
Atp11c |
ATPase, class VI, type 11C |
increases expression |
ISO |
Buspirone results in increased expression of ATP11C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:60,223,283...60,404,853
Ensembl chr X:60,223,290...60,592,698
|
|
G |
Atp6v0b |
ATPase, H+ transporting, lysosomal V0 subunit B |
increases expression |
ISO |
Buspirone results in increased expression of ATP6V0B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:117,884,330...117,887,333
Ensembl chr 4:117,884,326...117,887,333
|
|
G |
Atp6v0e |
ATPase, H+ transporting, lysosomal V0 subunit E |
increases expression |
ISO |
Buspirone results in increased expression of ATP6V0E1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:26,676,396...26,699,647
Ensembl chr17:26,663,231...26,699,647
|
|
G |
Atp6v1g1 |
ATPase, H+ transporting, lysosomal V1 subunit G1 |
increases expression |
ISO |
Buspirone results in increased expression of ATP6V1G1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:63,544,765...63,550,701
Ensembl chr 4:63,544,772...63,550,750
|
|
G |
AU022252 |
expressed sequence AU022252 |
increases expression |
ISO |
Buspirone results in increased expression of RGD1564804 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:119,222,882...119,232,885
Ensembl chr 4:119,203,570...119,232,712
|
|
G |
Axl |
AXL receptor tyrosine kinase |
decreases expression |
ISO |
Buspirone results in decreased expression of AXL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:25,756,500...25,788,924
Ensembl chr 7:25,757,273...25,788,705
|
|
G |
Azin1 |
antizyme inhibitor 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of AZIN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:38,487,430...38,519,294
Ensembl chr15:38,487,427...38,519,266
|
|
G |
B4galnt1 |
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
increases expression |
ISO |
Buspirone results in increased expression of B4GALNT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:127,165,156...127,172,340
Ensembl chr10:127,165,225...127,172,330
|
|
G |
Baiap2l1 |
BAI1-associated protein 2-like 1 |
increases expression |
ISO |
Buspirone results in increased expression of BAIAP2L1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:144,264,525...144,358,112
Ensembl chr 5:144,264,526...144,358,112
|
|
G |
Bgn |
biglycan |
decreases expression |
ISO |
Buspirone results in decreased expression of BGN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:73,483,601...73,495,936
Ensembl chr X:73,483,602...73,495,933
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
decreases expression |
ISO |
Buspirone results in decreased expression of BHLHE40 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:108,660,629...108,666,925
Ensembl chr 6:108,660,629...108,666,925
|
|
G |
Blvrb |
biliverdin reductase B (flavin reductase (NADPH)) |
increases expression |
ISO |
Buspirone results in increased expression of BLVRB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:27,447,978...27,465,981
Ensembl chr 7:27,447,978...27,466,144
|
|
G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
increases expression |
ISO |
Buspirone results in increased expression of BNIP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:138,890,836...138,909,506
Ensembl chr 7:138,890,836...138,909,519
|
|
G |
Bola1 |
bolA-like 1 (E. coli) |
increases expression |
ISO |
Buspirone results in increased expression of BOLA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:96,196,583...96,198,483
Ensembl chr 3:96,196,588...96,219,709
|
|
G |
Bpgm |
2,3-bisphosphoglycerate mutase |
decreases expression |
ISO |
Buspirone results in decreased expression of BPGM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:34,476,356...34,505,136
Ensembl chr 6:34,476,207...34,505,613
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of BTG2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:134,074,865...134,079,155
Ensembl chr 1:134,075,170...134,079,120
|
|
G |
C1qb |
complement component 1, q subcomponent, beta polypeptide |
decreases expression |
ISO |
Buspirone results in decreased expression of C1QB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:136,880,126...136,886,200
Ensembl chr 4:136,880,129...136,886,187
|
|
G |
C6 |
complement component 6 |
decreases expression |
ISO |
Buspirone results in decreased expression of C6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:4,727,067...4,804,045
Ensembl chr15:4,727,175...4,814,967
|
|
G |
C8g |
complement component 8, gamma polypeptide |
increases expression |
ISO |
Buspirone results in increased expression of C8G mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:25,498,650...25,501,777
Ensembl chr 2:25,498,651...25,501,719
|
|
G |
Cald1 |
caldesmon 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of CALD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:34,598,495...34,775,469
Ensembl chr 6:34,598,500...34,775,473
|
|
G |
Calm1 |
calmodulin 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of CALM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:100,199,435...100,209,824
Ensembl chr12:100,199,435...100,209,814
|
|
G |
Calm2 |
calmodulin 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of CALM2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:87,433,401...87,446,935
Ensembl chr12:100,199,435...100,209,814 Ensembl chr17:100,199,435...100,209,814
|
|
G |
Calr |
calreticulin |
decreases expression |
ISO |
Buspirone results in decreased expression of CALR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:84,842,088...84,846,931
Ensembl chr 8:84,841,850...84,846,934
|
|
G |
Cap1 |
CAP, adenylate cyclase-associated protein 1 (yeast) |
decreases expression |
ISO |
Buspirone results in decreased expression of CAP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:122,859,048...122,886,076
Ensembl chr 4:122,859,047...122,886,056
|
|
G |
Car3 |
carbonic anhydrase 3 |
decreases expression |
ISO |
Buspirone results in decreased expression of CAR3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:14,863,538...14,872,381
Ensembl chr 3:14,863,512...14,872,523
|
|
G |
Car5a |
carbonic anhydrase 5a, mitochondrial |
increases expression |
ISO |
Buspirone results in increased expression of CAR5A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:121,916,135...121,944,912
Ensembl chr 8:121,916,126...121,944,904
|
|
G |
Casp3 |
caspase 3 |
decreases expression |
ISO |
Buspirone results in decreased expression of CASP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:46,617,291...46,639,698
Ensembl chr 8:46,617,291...46,639,689
|
|
G |
Casp6 |
caspase 6 |
increases expression |
ISO |
Buspirone results in increased expression of CASP6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:129,901,415...129,914,112
Ensembl chr 3:129,901,425...129,914,103
|
|
G |
Casp7 |
caspase 7 |
decreases expression |
ISO |
Buspirone results in decreased expression of CASP7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:56,396,833...56,442,348
Ensembl chr19:56,397,129...56,442,344
|
|
G |
Cat |
catalase |
increases expression |
ISO |
Buspirone results in increased expression of CAT protein |
CTD |
PMID:19800952 |
|
NCBI chr 2:103,453,904...103,485,153
Ensembl chr 2:103,453,849...103,485,160
|
|
G |
Cbr4 |
carbonyl reductase 4 |
increases expression |
ISO |
Buspirone results in increased expression of CBR4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:61,487,734...61,503,500
Ensembl chr 8:61,487,734...61,506,694
|
|
G |
Ccdc6 |
coiled-coil domain containing 6 |
increases expression |
ISO |
Buspirone results in increased expression of CCDC6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:70,096,878...70,193,200
Ensembl chr10:70,097,121...70,193,200
|
|
G |
Ccdc80 |
coiled-coil domain containing 80 |
decreases expression |
ISO |
Buspirone results in decreased expression of CCDC80 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:45,093,407...45,127,924
Ensembl chr16:45,093,402...45,128,077
|
|
G |
Ccl6 |
chemokine (C-C motif) ligand 6 |
decreases expression |
ISO |
Buspirone results in decreased expression of CCL6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:83,587,886...83,593,087
Ensembl chr11:83,587,882...83,593,087
|
|
G |
Ccnb2 |
cyclin B2 |
decreases expression |
ISO |
Buspirone results in decreased expression of CCNB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:70,407,689...70,421,554
Ensembl chr 9:70,407,692...70,421,547
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
Buspirone results in decreased expression of CCND1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:144,929,931...144,939,831
Ensembl chr 7:144,929,931...144,939,925
|
|
G |
Cd164 |
CD164 antigen |
decreases expression |
ISO |
Buspirone results in decreased expression of CD164 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:41,519,500...41,531,042
Ensembl chr10:41,519,414...41,531,048
|
|
G |
Cd5l |
CD5 antigen-like |
decreases expression |
ISO |
Buspirone results in decreased expression of CD5L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:87,357,881...87,371,074
Ensembl chr 3:87,357,881...87,371,073
|
|
G |
Cd68 |
CD68 antigen |
decreases expression |
ISO |
Buspirone results in decreased expression of CD68 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:69,664,213...69,666,170
Ensembl chr11:69,664,213...69,666,153
|
|
G |
Cd74 |
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) |
decreases expression |
ISO |
Buspirone results in decreased expression of CD74 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:60,803,849...60,812,652
Ensembl chr18:60,803,848...60,812,652
|
|
G |
Cdc20 |
cell division cycle 20 |
decreases expression |
ISO |
Buspirone results in decreased expression of CDC20 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:118,432,901...118,437,343
Ensembl chr 4:118,432,901...118,437,352
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of CDK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:69,335,146...69,352,912
Ensembl chr10:69,335,146...69,352,938
|
|
G |
Cdkn2c |
cyclin dependent kinase inhibitor 2C |
decreases expression |
ISO |
Buspirone results in decreased expression of CDKN2C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:109,660,876...109,666,756
Ensembl chr 4:109,660,876...109,667,189
|
|
G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
decreases expression |
ISO |
Buspirone results in decreased expression of CDKN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:46,760,461...46,771,530
Ensembl chr14:46,760,541...46,771,669
|
|
G |
Ceacam1 |
carcinoembryonic antigen-related cell adhesion molecule 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of CEACAM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:25,461,702...25,477,647
Ensembl chr 7:25,461,707...25,477,603
|
|
G |
Ceacam10 |
carcinoembryonic antigen-related cell adhesion molecule 10 |
decreases expression |
ISO |
Buspirone results in decreased expression of CEACAM10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:24,777,167...24,784,656
Ensembl chr 7:24,777,206...24,784,657
|
|
G |
Cep20 |
centrosomal protein 20 |
decreases expression |
ISO |
Buspirone results in decreased expression of CEP20 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:14,299,241...14,318,229
Ensembl chr16:14,299,244...14,317,405
|
|
G |
Cfl1 |
cofilin 1, non-muscle |
decreases expression |
ISO |
Buspirone results in decreased expression of CFL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:5,490,455...5,494,031
Ensembl chr19:5,490,455...5,495,201
|
|
G |
Cgn |
cingulin |
decreases expression |
ISO |
Buspirone results in decreased expression of CGN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:94,760,069...94,787,725
Ensembl chr 3:94,760,069...94,786,515
|
|
G |
Chpt1 |
choline phosphotransferase 1 |
increases expression |
ISO |
Buspirone results in increased expression of CHPT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:88,469,513...88,503,970
Ensembl chr10:88,452,745...88,504,073
|
|
G |
Churc1 |
churchill domain containing 1 |
increases expression |
ISO |
Buspirone results in increased expression of CHURC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:76,765,538...76,783,180
Ensembl chr12:76,765,538...76,783,180
|
|
G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of CKS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:51,645,232...51,650,662
Ensembl chr13:51,645,232...51,650,660
|
|
G |
Clec4f |
C-type lectin domain family 4, member f |
decreases expression |
ISO |
Buspirone results in decreased expression of CLEC4F mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:83,644,542...83,656,116
Ensembl chr 6:83,644,542...83,656,187
|
|
G |
Clic1 |
chloride intracellular channel 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of CLIC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:35,050,243...35,058,719
Ensembl chr17:35,049,966...35,058,749
|
|
G |
Clpb |
ClpB caseinolytic peptidase B |
decreases expression |
ISO |
Buspirone results in decreased expression of CLPB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:101,663,596...101,795,460
Ensembl chr 7:101,663,633...101,795,506
|
|
G |
Cltb |
clathrin, light polypeptide (Lcb) |
increases expression |
ISO |
Buspirone results in increased expression of CLTB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:54,592,386...54,611,373
Ensembl chr13:54,592,401...54,611,344
|
|
G |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
decreases expression |
ISO |
Buspirone results in decreased expression of CMTM6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:114,731,157...114,749,359
Ensembl chr 9:114,731,116...114,749,344
|
|
G |
Cnppd1 |
cyclin Pas1/PHO80 domain containing 1 |
increases expression |
ISO |
Buspirone results in increased expression of CNPPD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:75,135,762...75,142,744
Ensembl chr 1:75,134,554...75,142,711
|
|
G |
Cnr1 |
cannabinoid receptor 1 (brain) |
affects response to substance |
EXP |
CNR1 affects the susceptibility to Buspirone |
CTD |
PMID:15081793 |
|
NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
|
|
G |
Cobll1 |
Cobl-like 1 |
increases expression |
ISO |
Buspirone results in increased expression of COBLL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:65,088,339...65,239,398
Ensembl chr 2:65,088,339...65,239,403
|
|
G |
Col14a1 |
collagen, type XIV, alpha 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of COL14A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:55,307,644...55,520,803
Ensembl chr15:55,307,750...55,520,803
|
|
G |
Col1a2 |
collagen, type I, alpha 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of COL1A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
|
|
G |
Col3a1 |
collagen, type III, alpha 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of COL3A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:45,311,538...45,349,706
Ensembl chr 1:45,311,538...45,349,706
|
|
G |
Commd5 |
COMM domain containing 5 |
increases expression |
ISO |
Buspirone results in increased expression of COMMD5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:76,899,941...76,901,297
Ensembl chr15:76,899,910...76,901,305
|
|
G |
Copg1 |
coatomer protein complex, subunit gamma 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of COPG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:87,887,819...87,913,595
Ensembl chr 6:87,887,814...87,913,595
|
|
G |
Coro1c |
coronin, actin binding protein 1C |
decreases expression |
ISO |
Buspirone results in decreased expression of CORO1C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:113,842,439...113,908,706
Ensembl chr 5:113,842,436...113,908,758
|
|
G |
Cox14 |
cytochrome c oxidase assembly protein 14 |
increases expression |
ISO |
Buspirone results in increased expression of COX14 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:99,725,618...99,728,136
Ensembl chr15:99,725,647...99,729,532
|
|
G |
Cox7a2l |
cytochrome c oxidase subunit 7A2 like |
increases expression |
ISO |
Buspirone results in increased expression of COX7A2L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:83,501,917...83,514,333
Ensembl chr17:83,501,918...83,517,330
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
increases expression |
ISO |
Buspirone results in increased expression of CPT1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:3,322,326...3,385,735
Ensembl chr19:3,322,334...3,385,733
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
increases expression |
ISO |
Buspirone results in increased expression of CPT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:107,903,982...107,923,589
Ensembl chr 4:107,903,981...107,923,610
|
|
G |
Crem |
cAMP responsive element modulator |
decreases expression |
ISO |
Buspirone results in decreased expression of CREM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:3,266,354...3,337,773
Ensembl chr18:3,266,048...3,337,748
|
|
G |
Cry1 |
cryptochrome 1 (photolyase-like) |
decreases expression |
ISO |
Buspirone results in decreased expression of CRY1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:85,131,700...85,185,054
Ensembl chr10:85,131,700...85,185,064
|
|
G |
Cse1l |
chromosome segregation 1-like (S. cerevisiae) |
decreases expression |
ISO |
Buspirone results in decreased expression of CSE1L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:166,906,041...166,946,389
Ensembl chr 2:166,906,040...166,946,389
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
decreases expression |
ISO |
Buspirone results in decreased expression of CSF1R mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:61,105,572...61,131,139
Ensembl chr18:61,100,598...61,132,149
|
|
G |
Csnk2a2 |
casein kinase 2, alpha prime polypeptide |
increases expression |
ISO |
Buspirone results in increased expression of CSNK2A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:95,446,096...95,488,868
Ensembl chr 8:95,446,096...95,490,039
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of CSRP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:135,720,063...135,752,229
Ensembl chr 1:135,720,061...135,752,232
|
|
G |
Ctsd |
cathepsin D |
increases expression |
ISO |
Buspirone results in increased expression of CTSD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:142,375,910...142,387,827
Ensembl chr 7:142,375,911...142,388,038
|
|
G |
Ctsl |
cathepsin L |
increases expression |
ISO |
Buspirone results in increased expression of CTSL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:64,361,890...64,370,772
Ensembl chr13:64,359,337...64,370,890
|
|
G |
Ctss |
cathepsin S |
decreases expression |
ISO |
Buspirone results in decreased expression of CTSS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:95,526,786...95,556,405
Ensembl chr 3:95,526,786...95,556,403
|
|
G |
Ctsz |
cathepsin Z |
decreases expression |
ISO |
Buspirone results in decreased expression of CTSZ mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:174,427,494...174,439,039
Ensembl chr 2:174,427,493...174,439,039
|
|
G |
Cxcl11 |
chemokine (C-X-C motif) ligand 11 |
increases expression |
ISO |
Buspirone results in increased expression of CXCL11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:92,359,544...92,363,296
Ensembl chr 5:92,359,544...92,365,485
|
|
G |
Cybb |
cytochrome b-245, beta polypeptide |
decreases expression |
ISO |
Buspirone results in decreased expression of CYBB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:9,435,252...9,487,766
Ensembl chr X:9,435,252...9,487,771
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
increases expression |
ISO |
Buspirone results in increased expression of CYP27A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:74,713,148...74,737,897
Ensembl chr 1:74,713,574...74,737,892
|
|
G |
Cyp2d22 |
cytochrome P450, family 2, subfamily d, polypeptide 22 |
increases oxidation increases expression |
ISO |
CYP2D6 protein results in increased oxidation of Buspirone Buspirone results in increased expression of CYP2D4 mRNA |
CTD |
PMID:15640381 PMID:24136188 |
|
NCBI chr15:82,370,527...82,380,260
Ensembl chr15:82,370,527...82,380,260
|
|
G |
Cyp3a13 |
cytochrome P450, family 3, subfamily a, polypeptide 13 |
increases oxidation increases expression |
ISO |
CYP3A5 protein results in increased oxidation of Buspirone Buspirone results in increased expression of CYP3A9 mRNA |
CTD |
PMID:15640381 PMID:24136188 |
|
NCBI chr 5:137,892,933...137,925,610
Ensembl chr 5:137,892,932...137,921,619
|
|
G |
Cyp4a12b |
cytochrome P450, family 4, subfamily a, polypeptide 12B |
increases expression |
ISO |
Buspirone results in increased expression of CYP4A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:115,411,624...115,439,034
Ensembl chr 4:115,411,624...115,439,034
|
|
G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
increases expression |
ISO |
Buspirone results in increased expression of CYP4B1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:115,624,698...115,647,721
Ensembl chr 4:115,624,725...115,647,723
|
|
G |
Cyp4f14 |
cytochrome P450, family 4, subfamily f, polypeptide 14 |
decreases expression |
ISO |
Buspirone results in decreased expression of CYP4F1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:32,903,357...32,917,376
Ensembl chr17:32,905,070...32,917,342
|
|
G |
Cyp8b1 |
cytochrome P450, family 8, subfamily b, polypeptide 1 |
increases expression |
ISO |
Buspirone results in increased expression of CYP8B1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:121,914,356...121,916,305
Ensembl chr 9:121,914,356...121,916,305
|
|
G |
Daam1 |
dishevelled associated activator of morphogenesis 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of DAAM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:71,830,950...71,992,376
Ensembl chr12:71,831,078...71,992,333
|
|
G |
Dab2 |
disabled 2, mitogen-responsive phosphoprotein |
decreases expression |
ISO |
Buspirone results in decreased expression of DAB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:6,299,788...6,440,715
Ensembl chr15:6,299,788...6,440,712
|
|
G |
Dapk1 |
death associated protein kinase 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of DAPK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:60,601,723...60,763,191
Ensembl chr13:60,601,947...60,763,191
|
|
G |
Dbi |
diazepam binding inhibitor |
decreases expression |
ISO |
Buspirone results in decreased expression of DBI mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:120,113,280...120,121,096
Ensembl chr 1:120,113,280...120,121,078
|
|
G |
Ddc |
dopa decarboxylase |
decreases expression |
ISO |
Buspirone results in decreased expression of DDC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:11,814,101...11,898,144
Ensembl chr11:11,814,101...11,898,144
|
|
G |
Ddhd1 |
DDHD domain containing 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of DDHD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:45,593,171...45,658,143
Ensembl chr14:45,588,467...45,658,143
|
|
G |
Ddx1 |
DEAD box helicase 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of DDX1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:13,219,307...13,249,174
Ensembl chr12:13,216,973...13,249,213
|
|
G |
Ddx58 |
DEAD/H box helicase 58 |
decreases expression |
ISO |
Buspirone results in decreased expression of DDX58 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:40,203,777...40,239,825
Ensembl chr 4:40,203,773...40,239,828
|
|
G |
Decr1 |
2,4-dienoyl CoA reductase 1, mitochondrial |
increases expression |
ISO |
Buspirone results in increased expression of DECR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:15,917,240...15,945,377
Ensembl chr 4:15,917,240...15,945,507
|
|
G |
Dek |
DEK proto-oncogene (DNA binding) |
decreases expression |
ISO |
Buspirone results in decreased expression of DEK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:47,084,767...47,107,530
Ensembl chr13:47,084,775...47,106,201
|
|
G |
Deptor |
DEP domain containing MTOR-interacting protein |
increases expression |
ISO |
Buspirone results in increased expression of DEPTOR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:55,112,317...55,259,273
Ensembl chr15:55,112,317...55,259,271
|
|
G |
Dhrs7 |
dehydrogenase/reductase (SDR family) member 7 |
increases expression |
ISO |
Buspirone results in increased expression of DHRS7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:72,650,353...72,664,828
Ensembl chr12:72,650,353...72,664,909
|
|
G |
Dld |
dihydrolipoamide dehydrogenase |
decreases expression |
ISO |
Buspirone results in decreased expression of DLD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:31,331,562...31,351,471
Ensembl chr12:31,331,277...31,351,453
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
increases expression |
ISO |
Buspirone results in increased expression of DNAJB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:83,608,175...83,612,653
Ensembl chr 8:83,608,193...83,612,653
|
|
G |
Dnajc9 |
DnaJ heat shock protein family (Hsp40) member C9 |
decreases expression |
ISO |
Buspirone results in decreased expression of DNAJC9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:20,384,638...20,388,910
Ensembl chr14:20,384,638...20,388,910
|
|
G |
Dpm1 |
dolichol-phosphate (beta-D) mannosyltransferase 1 |
increases expression |
ISO |
Buspirone results in increased expression of DPM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:168,209,048...168,230,379
Ensembl chr 2:168,209,048...168,230,591
|
|
G |
Dpm3 |
dolichyl-phosphate mannosyltransferase polypeptide 3 |
increases expression |
ISO |
Buspirone results in increased expression of DPM3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:89,257,065...89,267,079
Ensembl chr 3:89,259,358...89,267,079
|
|
G |
Dpysl2 |
dihydropyrimidinase-like 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of DPYSL2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:66,802,864...66,911,041
Ensembl chr14:66,802,864...66,868,688
|
|
G |
Dtymk |
deoxythymidylate kinase |
decreases expression |
ISO |
Buspirone results in decreased expression of DTYMK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:93,792,576...93,802,068
Ensembl chr 1:93,792,576...93,801,934
|
|
G |
Dut |
deoxyuridine triphosphatase |
decreases expression |
ISO |
Buspirone results in decreased expression of DUT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:125,247,248...125,259,049
Ensembl chr 2:125,247,190...125,258,608
|
|
G |
Dynll1 |
dynein light chain LC8-type 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of DYNLL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:115,297,110...115,300,990
Ensembl chr 5:115,297,110...115,300,999
|
|
G |
Dynlt3 |
dynein light chain Tctex-type 3 |
decreases expression |
ISO |
Buspirone results in decreased expression of DYNLT3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:9,654,270...9,662,983
Ensembl chr X:9,654,267...9,663,003
|
|
G |
Ech1 |
enoyl coenzyme A hydratase 1, peroxisomal |
increases expression |
ISO |
Buspirone results in increased expression of ECH1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:28,825,338...28,832,239
Ensembl chr 7:28,825,217...28,832,247
|
|
G |
Echdc1 |
enoyl Coenzyme A hydratase domain containing 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of ECHDC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:29,298,144...29,346,661
Ensembl chr10:29,313,166...29,347,469
|
|
G |
Echdc3 |
enoyl Coenzyme A hydratase domain containing 3 |
increases expression |
ISO |
Buspirone results in increased expression of ECHDC3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:6,188,465...6,212,994
Ensembl chr 2:6,188,465...6,213,033
|
|
G |
Eci1 |
enoyl-Coenzyme A delta isomerase 1 |
increases expression |
ISO |
Buspirone results in increased expression of ECI1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:24,426,683...24,439,316
Ensembl chr17:24,426,641...24,439,348
|
|
G |
Edem1 |
ER degradation enhancer, mannosidase alpha-like 1 |
increases expression |
ISO |
Buspirone results in increased expression of EDEM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:108,824,045...108,859,356
Ensembl chr 6:108,828,641...108,859,356
|
|
G |
Eftud2 |
elongation factor Tu GTP binding domain containing 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of EFTUD2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:102,838,472...102,880,984
Ensembl chr11:102,838,473...102,880,985
|
|
G |
Ehbp1 |
EH domain binding protein 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of EHBP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:22,005,825...22,287,083
Ensembl chr11:22,005,828...22,342,292
|
|
G |
Ei24 |
etoposide induced 2.4 mRNA |
increases expression |
ISO |
Buspirone results in increased expression of EI24 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:36,779,153...36,797,334
Ensembl chr 9:36,779,159...36,797,393
|
|
G |
Eif3c |
eukaryotic translation initiation factor 3, subunit C |
decreases expression |
ISO |
Buspirone results in decreased expression of EIF3C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:126,546,911...126,566,366
Ensembl chr 7:126,546,455...126,566,411
|
|
G |
Eif3l |
eukaryotic translation initiation factor 3, subunit L |
decreases expression |
ISO |
Buspirone results in decreased expression of EIF3L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:79,075,223...79,094,400
Ensembl chr15:79,075,179...79,094,405
|
|
G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
increases expression |
ISO |
Buspirone results in increased expression of EIF4A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:23,107,468...23,114,132
Ensembl chr16:23,107,444...23,114,136
|
|
G |
Eif4b |
eukaryotic translation initiation factor 4B |
increases expression |
ISO |
Buspirone results in increased expression of EIF4B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:102,073,773...102,097,173
Ensembl chr15:102,073,773...102,097,173
|
|
G |
Elovl5 |
ELOVL family member 5, elongation of long chain fatty acids (yeast) |
decreases expression |
ISO |
Buspirone results in decreased expression of ELOVL5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:77,917,365...77,984,519
Ensembl chr 9:77,917,364...77,984,519
|
|
G |
Elovl6 |
ELOVL family member 6, elongation of long chain fatty acids (yeast) |
decreases expression |
ISO |
Buspirone results in decreased expression of ELOVL6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:129,532,386...129,638,495
Ensembl chr 3:129,532,355...129,638,495
|
|
G |
Enpep |
glutamyl aminopeptidase |
decreases expression |
ISO |
Buspirone results in decreased expression of ENPEP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:129,269,177...129,332,749
Ensembl chr 3:129,269,175...129,332,720
|
|
G |
Ephx1 |
epoxide hydrolase 1, microsomal |
decreases expression |
ISO |
Buspirone results in decreased expression of EPHX1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:180,989,556...181,017,569
Ensembl chr 1:180,976,210...181,020,904
|
|
G |
Erg28 |
ergosterol biosynthesis 28 |
increases expression |
ISO |
Buspirone results in increased expression of ERG28 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:85,815,447...85,824,893
Ensembl chr12:85,815,448...85,824,550
|
|
G |
Ergic1 |
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of ERGIC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:26,560,762...26,656,934
Ensembl chr17:26,561,489...26,656,934
|
|
G |
Erp29 |
endoplasmic reticulum protein 29 |
decreases expression |
ISO |
Buspirone results in decreased expression of ERP29 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:121,444,753...121,452,474
Ensembl chr 5:121,428,590...121,452,506
|
|
G |
Etnk2 |
ethanolamine kinase 2 |
increases expression |
ISO |
Buspirone results in increased expression of ETNK2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:133,363,463...133,380,318
Ensembl chr 1:133,363,572...133,380,336
|
|
G |
Ewsr1 |
Ewing sarcoma breakpoint region 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of EWSR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:5,069,687...5,099,107
Ensembl chr11:5,069,689...5,099,266
|
|
G |
Exosc5 |
exosome component 5 |
increases expression |
ISO |
Buspirone results in increased expression of EXOSC5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:25,659,153...25,668,032
Ensembl chr 7:25,659,164...25,671,368
|
|
G |
Fabp5 |
fatty acid binding protein 5, epidermal |
decreases expression |
ISO |
Buspirone results in decreased expression of FABP5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:10,012,585...10,016,610
Ensembl chr 3:10,012,548...10,016,607
|
|
G |
Fads1 |
fatty acid desaturase 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of FADS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:10,182,877...10,196,874
Ensembl chr19:10,182,888...10,196,877
|
|
G |
Fads2 |
fatty acid desaturase 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of FADS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:10,062,765...10,101,503
Ensembl chr19:10,062,765...10,101,746
|
|
G |
Fam111a |
family with sequence similarity 111, member A |
decreases expression |
ISO |
Buspirone results in decreased expression of FAM111A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:12,573,510...12,589,769
Ensembl chr19:12,545,740...12,589,768
|
|
G |
Fam126b |
family with sequence similarity 126, member B |
increases expression |
ISO |
Buspirone results in increased expression of FAM126B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:58,522,806...58,586,333
Ensembl chr 1:58,522,806...58,586,323
|
|
G |
Fam98a |
family with sequence similarity 98, member A |
decreases expression |
ISO |
Buspirone results in decreased expression of FAM98A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:75,537,085...75,551,946
Ensembl chr17:75,537,086...75,551,946
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
ISO |
Buspirone results in decreased expression of FASN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:120,805,958...120,825,166
Ensembl chr11:120,805,846...120,824,547
|
|
G |
Fat1 |
FAT atypical cadherin 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of FAT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:44,933,100...45,052,257
Ensembl chr 8:44,935,447...45,052,257
|
|
G |
Fbxo31 |
F-box protein 31 |
increases expression |
ISO |
Buspirone results in increased expression of FBXO31 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:121,549,443...121,578,864
Ensembl chr 8:121,549,440...121,578,806
|
|
G |
Fbxw2 |
F-box and WD-40 domain protein 2 |
increases expression |
ISO |
Buspirone results in increased expression of FBXW2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:34,804,364...34,826,282
Ensembl chr 2:34,804,514...34,826,311
|
|
G |
Fcgr3 |
Fc receptor, IgG, low affinity III |
decreases expression |
ISO |
Buspirone results in decreased expression of FCGR2A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:171,051,169...171,065,915
Ensembl chr 1:171,051,174...171,064,935
|
|
G |
Fcna |
ficolin A |
decreases expression |
ISO |
Buspirone results in decreased expression of FCNA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:25,624,665...25,635,440
Ensembl chr 2:25,624,666...25,628,030
|
|
G |
Fez2 |
fasciculation and elongation protein zeta 2 (zygin II) |
decreases expression |
ISO |
Buspirone results in decreased expression of FEZ2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:78,369,212...78,418,152
Ensembl chr17:78,369,212...78,418,152
|
|
G |
Fga |
fibrinogen alpha chain |
decreases expression |
ISO |
Buspirone results in decreased expression of FGA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:83,026,153...83,033,627
Ensembl chr 3:83,026,076...83,033,627
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of FGFR2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:130,162,451...130,266,808
Ensembl chr 7:130,162,451...133,123,350
|
|
G |
Flcn |
folliculin |
increases expression |
ISO |
Buspirone results in increased expression of FLCN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:59,791,408...59,810,039
Ensembl chr11:59,791,408...59,810,016
|
|
G |
Fmo3 |
flavin containing monooxygenase 3 |
increases expression |
ISO |
Buspirone results in increased expression of FMO3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:162,953,799...162,984,528
Ensembl chr 1:162,953,800...162,984,528
|
|
G |
Fmo5 |
flavin containing monooxygenase 5 |
increases expression |
ISO |
Buspirone results in increased expression of FMO5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:97,609,938...97,655,287
Ensembl chr 3:97,628,804...97,655,282
|
|
G |
Foxa3 |
forkhead box A3 |
increases expression |
ISO |
Buspirone results in increased expression of FOXA3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:19,013,283...19,023,539
Ensembl chr 7:19,013,284...19,023,538
|
|
G |
Foxo1 |
forkhead box O1 |
increases expression |
ISO |
Buspirone results in increased expression of FOXO1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:52,268,337...52,350,109
Ensembl chr 3:52,268,336...52,353,221
|
|
G |
Fstl1 |
follistatin-like 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of FSTL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:37,777,055...37,836,516
Ensembl chr16:37,776,873...37,836,514
|
|
G |
Ftcd |
formiminotransferase cyclodeaminase |
increases expression |
ISO |
Buspirone results in increased expression of FTCD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:76,575,648...76,590,338
Ensembl chr10:76,575,648...76,590,338
|
|
G |
Fus |
fused in sarcoma |
decreases expression |
ISO |
Buspirone results in decreased expression of FUS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:127,966,789...127,982,032
Ensembl chr 7:127,967,457...127,985,701
|
|
G |
Fxyd1 |
FXYD domain-containing ion transport regulator 1 |
increases expression |
ISO |
Buspirone results in increased expression of FXYD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:31,051,678...31,055,873
Ensembl chr 7:31,051,678...31,057,199
|
|
G |
G0s2 |
G0/G1 switch gene 2 |
increases expression |
ISO |
Buspirone results in increased expression of G0S2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:193,272,160...193,273,188
Ensembl chr 1:193,272,161...193,273,217
|
|
G |
G6pdx |
glucose-6-phosphate dehydrogenase X-linked |
decreases expression |
ISO |
Buspirone results in decreased expression of G6PD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:74,409,483...74,428,880
Ensembl chr X:74,409,483...74,429,194
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible 45 gamma |
decreases expression |
ISO |
Buspirone results in decreased expression of GADD45G mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:51,846,675...51,848,475
Ensembl chr13:51,846,678...51,848,468
|
|
G |
Galnt1 |
polypeptide N-acetylgalactosaminyltransferase 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of GALNT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:24,205,321...24,286,816
Ensembl chr18:24,205,344...24,286,818
|
|
G |
Gars |
glycyl-tRNA synthetase |
decreases expression |
ISO |
Buspirone results in decreased expression of GARS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:55,038,001...55,079,504
Ensembl chr 6:55,038,007...55,079,500
|
|
G |
Gas5 |
growth arrest specific 5 |
increases expression |
ISO |
Buspirone results in increased expression of GAS5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:161,034,601...161,038,539
Ensembl chr 1:161,034,422...161,038,539
|
|
G |
Gbe1 |
glucan (1,4-alpha-), branching enzyme 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of GBE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:70,313,949...70,569,720
Ensembl chr16:70,313,949...70,569,716
|
|
G |
Gcdh |
glutaryl-Coenzyme A dehydrogenase |
increases expression |
ISO |
Buspirone results in increased expression of GCDH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:84,886,387...84,893,921
Ensembl chr 8:84,886,393...84,893,921
|
|
G |
Gchfr |
GTP cyclohydrolase I feedback regulator |
increases expression |
ISO |
Buspirone results in increased expression of GCHFR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:119,167,788...119,172,389
Ensembl chr 2:119,167,773...119,172,390
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
decreases expression |
ISO |
Buspirone results in decreased expression of GCLC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:77,754,535...77,794,489
Ensembl chr 9:77,754,535...77,794,485
|
|
G |
Gde1 |
glycerophosphodiester phosphodiesterase 1 |
increases expression |
ISO |
Buspirone results in increased expression of GDE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:118,688,558...118,705,738
Ensembl chr 7:118,688,545...118,705,778
|
|
G |
Gdi2 |
guanosine diphosphate (GDP) dissociation inhibitor 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of GDI2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:3,538,075...3,566,261
Ensembl chr13:3,538,063...3,567,871
|
|
G |
Gfm1 |
G elongation factor, mitochondrial 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of GFM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:67,430,115...67,475,068
Ensembl chr 3:67,430,096...67,476,529
|
|
G |
Ggcx |
gamma-glutamyl carboxylase |
decreases expression |
ISO |
Buspirone results in decreased expression of GGCX mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:72,414,279...72,433,359
Ensembl chr 6:72,414,308...72,430,712
|
|
G |
Ghr |
growth hormone receptor |
decreases expression |
ISO |
Buspirone results in decreased expression of GHR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:3,317,755...3,583,352
Ensembl chr15:3,317,760...3,583,492
|
|
G |
Gldc |
glycine decarboxylase |
decreases expression |
ISO |
Buspirone results in decreased expression of GLDC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:30,098,441...30,175,441
Ensembl chr19:30,098,447...30,175,429
|
|
G |
Glrx |
glutaredoxin |
increases expression |
ISO |
Buspirone results in increased expression of GLRX mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:75,839,885...75,850,151
Ensembl chr13:75,839,868...75,850,154
|
|
G |
Glyat |
glycine-N-acyltransferase |
increases expression |
ISO |
Buspirone results in increased expression of GLYAT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:12,633,308...12,651,737
Ensembl chr19:12,633,308...12,653,911
|
|
G |
Gm5617 |
predicted gene 5617 |
increases expression |
ISO |
Buspirone results in increased expression of RGD1563941 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:48,495,343...48,495,975
Ensembl chr 9:48,495,442...48,495,972
|
|
G |
Gm6563 |
predicted pseudogene 6563 |
decreases expression |
ISO |
Buspirone results in decreased expression of SARNP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:23,675,811...23,676,735
Ensembl chr19:23,675,848...23,676,480
|
|
G |
Gnpnat1 |
glucosamine-phosphate N-acetyltransferase 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of GNPNAT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:45,376,421...45,388,987
Ensembl chr14:45,376,334...45,404,913
|
|
G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
decreases expression |
ISO |
Buspirone results in decreased expression of GPAM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:55,067,635...55,127,319
Ensembl chr19:55,067,268...55,127,238
|
|
G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 (soluble) |
decreases expression |
ISO |
Buspirone results in decreased expression of GPD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:99,717,587...99,725,014
Ensembl chr15:99,717,515...99,725,005
|
|
G |
Gpt |
glutamic pyruvic transaminase, soluble |
increases expression |
ISO |
Buspirone results in increased expression of GPT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:76,696,726...76,699,675
Ensembl chr15:76,695,716...76,699,686
|
|
G |
Gspt1 |
G1 to S phase transition 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of GSPT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:11,216,240...11,254,325
Ensembl chr16:11,219,292...11,254,325
|
|
G |
Gstp1 |
glutathione S-transferase, pi 1 |
increases expression |
ISO |
Buspirone results in increased expression of GSTP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:4,035,411...4,037,912
Ensembl chr19:4,035,407...4,037,985
|
|
G |
Gstt2 |
glutathione S-transferase, theta 2 |
increases expression |
ISO |
Buspirone results in increased expression of GSTT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:75,831,842...75,837,419
Ensembl chr10:75,831,114...75,837,424
|
|
G |
H1f0 |
H1.0 linker histone |
decreases expression |
ISO |
Buspirone results in decreased expression of H1F0 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:79,028,212...79,030,504
Ensembl chr15:79,028,450...79,030,504
|
|
G |
H2-Aa |
histocompatibility 2, class II antigen A, alpha |
decreases expression |
ISO |
Buspirone results in decreased expression of RT1-BA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:34,282,744...34,287,823
Ensembl chr17:34,282,744...34,287,823
|
|
G |
H2-DMb2 |
histocompatibility 2, class II, locus Mb2 |
decreases expression |
ISO |
Buspirone results in decreased expression of HLA-DMB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:34,143,229...34,151,553
Ensembl chr17:34,143,307...34,151,555
|
|
G |
H2-Ea |
histocompatibility 2, class II antigen E alpha |
decreases expression |
ISO |
Buspirone results in decreased expression of RT1-DA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:34,341,952...34,344,645
Ensembl chr17:34,341,959...34,344,645
|
|
G |
H2-T23 |
histocompatibility 2, T region locus 23 |
decreases expression |
ISO |
Buspirone results in decreased expression of RT1-S3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:36,029,977...36,032,701
Ensembl chr17:36,029,773...36,032,855
|
|
G |
H2az1 |
H2A.Z variant histone 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of H2AZ1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:137,864,487...137,866,922
Ensembl chr 3:137,864,487...137,866,922
|
|
G |
Hacd2 |
3-hydroxyacyl-CoA dehydratase 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of HACD2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:35,022,421...35,109,190
Ensembl chr16:35,022,428...35,109,177
|
|
G |
Hacd3 |
3-hydroxyacyl-CoA dehydratase 3 |
decreases expression |
ISO |
Buspirone results in decreased expression of HACD3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:64,986,983...65,021,732
Ensembl chr 9:64,986,983...65,021,693
|
|
G |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
increases expression |
ISO |
Buspirone results in increased expression of HACL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:31,607,226...31,640,965
Ensembl chr14:31,598,730...31,641,286
|
|
G |
Hadhb |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
increases expression |
ISO |
Buspirone results in increased expression of HADHB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:30,155,253...30,184,593
Ensembl chr 5:30,155,248...30,184,593
|
|
G |
Hao1 |
hydroxyacid oxidase 1, liver |
decreases expression |
ISO |
Buspirone results in decreased expression of HAO1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:134,497,361...134,554,352
Ensembl chr 2:134,497,361...134,554,368
|
|
G |
Hat1 |
histone aminotransferase 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of HAT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:71,389,260...71,441,622
Ensembl chr 2:71,388,958...71,441,622
|
|
G |
Haus4 |
HAUS augmin-like complex, subunit 4 |
decreases expression |
ISO |
Buspirone results in decreased expression of HAUS4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:54,541,785...54,554,989
Ensembl chr14:54,541,785...54,554,616
|
|
G |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of HBA-A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:32,283,672...32,284,486
Ensembl chr11:32,283,511...32,284,465
|
|
G |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of HBA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:32,296,492...32,297,310
Ensembl chr11:32,296,489...32,297,298
|
|
G |
Hectd1 |
HECT domain E3 ubiquitin protein ligase 1 |
increases expression |
ISO |
Buspirone results in increased expression of HECTD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:51,743,721...51,829,757
Ensembl chr12:51,743,722...51,829,536
|
|
G |
Herpud1 |
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
increases expression |
ISO |
Buspirone results in increased expression of HERPUD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:94,386,429...94,395,371
Ensembl chr 8:94,386,438...94,395,377
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
increases expression |
ISO |
Buspirone results in increased expression of HES1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:30,065,357...30,067,796
Ensembl chr16:30,064,384...30,067,796
|
|
G |
Hes6 |
hairy and enhancer of split 6 |
decreases expression |
ISO |
Buspirone results in decreased expression of HES6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:91,411,483...91,414,038
Ensembl chr 1:91,411,483...91,414,038
|
|
G |
Hexb |
hexosaminidase B |
increases expression |
ISO |
Buspirone results in increased expression of HEXB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:97,176,331...97,198,357
Ensembl chr13:97,176,331...97,198,357
|
|
G |
Hhex |
hematopoietically expressed homeobox |
decreases expression |
ISO |
Buspirone results in decreased expression of HHEX mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:37,434,841...37,440,731
Ensembl chr19:37,434,810...37,440,731
|
|
G |
Hibch |
3-hydroxyisobutyryl-Coenzyme A hydrolase |
increases expression |
ISO |
Buspirone results in increased expression of HIBCH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:52,845,038...52,920,986
Ensembl chr 1:52,844,929...52,920,986
|
|
G |
Higd2a |
HIG1 domain family, member 2A |
increases expression |
ISO |
Buspirone results in increased expression of HIGD2A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:54,590,231...54,591,147
Ensembl chr13:54,590,207...54,591,158
|
|
G |
Hmgb2 |
high mobility group box 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of HMGB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:57,511,843...57,515,999
Ensembl chr 8:57,511,907...57,515,999
|
|
G |
Hmgn2 |
high mobility group nucleosomal binding domain 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of HMGN2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:133,964,739...133,967,991
Ensembl chr 4:133,964,738...133,968,650
|
|
G |
Hmgn3 |
high mobility group nucleosomal binding domain 3 |
decreases expression |
ISO |
Buspirone results in decreased expression of HMGN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:83,109,942...83,147,358
Ensembl chr 9:83,109,948...83,146,685
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
decreases expression |
ISO |
Buspirone results in decreased expression of HNRNPA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:103,239,943...103,246,698
Ensembl chr15:103,240,432...103,246,692
|
|
G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
decreases expression |
ISO |
Buspirone results in decreased expression of HNRNPA2B1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:51,460,434...51,470,048
Ensembl chr 6:51,460,932...51,469,894
|
|
G |
Hnrnpm |
heterogeneous nuclear ribonucleoprotein M |
decreases expression |
ISO |
Buspirone results in decreased expression of HNRNPM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:33,646,233...33,685,458
Ensembl chr17:33,646,233...33,686,860
|
|
G |
Hnrnpr |
heterogeneous nuclear ribonucleoprotein R |
decreases expression |
ISO |
Buspirone results in decreased expression of HNRNPR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:136,310,942...136,345,981
Ensembl chr 4:136,310,942...136,359,447
|
|
G |
Hprt |
hypoxanthine guanine phosphoribosyl transferase |
increases expression |
ISO |
Buspirone results in increased expression of HPRT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:52,988,078...53,021,660
Ensembl chr X:52,988,137...53,021,659
|
|
G |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
increases expression |
ISO |
Buspirone results in increased expression of HSDL2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:59,581,517...59,618,694
Ensembl chr 4:59,581,563...59,618,689
|
|
G |
Hspa13 |
heat shock protein 70 family, member 13 |
decreases expression |
ISO |
Buspirone results in decreased expression of HSPA13 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:75,755,190...75,767,276
Ensembl chr16:75,745,431...75,767,104
|
|
G |
Hspa5 |
heat shock protein 5 |
decreases expression |
ISO |
Buspirone results in decreased expression of HSPA5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:34,772,090...34,776,529
Ensembl chr 2:34,771,970...34,777,547
|
|
G |
Htatsf1 |
HIV TAT specific factor 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of HTATSF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:57,053,570...57,067,183
Ensembl chr X:57,053,583...57,067,183
|
|
G |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A |
multiple interactions |
ISO |
Buspirone binds to and affects the activity of HTR1A protein Buspirone binds to and results in decreased activity of HTR1A protein |
CTD |
PMID:2207497 PMID:15482641 |
|
NCBI chr13:105,443,693...105,448,133
Ensembl chr13:105,443,639...105,448,122
|
|
G |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A |
decreases expression |
ISO |
Buspirone results in decreased expression of HTR2A protein |
CTD |
PMID:1664741 |
|
NCBI chr14:74,640,874...74,706,859
Ensembl chr14:74,640,840...74,709,494
|
|
G |
Hyal3 |
hyaluronoglucosaminidase 3 |
decreases expression |
ISO |
Buspirone results in decreased expression of HYAL3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:107,581,296...107,587,359
Ensembl chr 9:107,580,818...107,587,359
|
|
G |
Iars |
isoleucine-tRNA synthetase |
decreases expression |
ISO |
Buspirone results in decreased expression of IARS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:49,682,130...49,734,267
Ensembl chr13:49,682,100...49,734,267
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of ICAM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:21,015,940...21,028,814
Ensembl chr 9:21,015,985...21,028,817
|
|
G |
Ifit2 |
interferon-induced protein with tetratricopeptide repeats 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of IFIT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:34,550,550...34,576,534
Ensembl chr19:34,550,694...34,576,419
|
|
G |
Ifitm2 |
interferon induced transmembrane protein 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of IFITM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:140,954,837...140,959,686
Ensembl chr 7:140,954,837...140,955,987
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of IGF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:87,858,265...87,937,047
Ensembl chr10:87,858,265...87,937,042
|
|
G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
decreases expression |
ISO |
Buspirone results in decreased expression of IGFBP7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:77,349,240...77,408,045
Ensembl chr 5:77,349,240...77,408,041
|
|
G |
Ik |
IK cytokine |
decreases expression |
ISO |
Buspirone results in decreased expression of IK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:36,744,656...36,757,639
Ensembl chr18:36,744,656...36,757,639
|
|
G |
Il6ra |
interleukin 6 receptor, alpha |
increases expression |
ISO |
Buspirone results in increased expression of IL6R mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:89,869,324...89,913,196
Ensembl chr 3:89,864,059...89,913,196
|
|
G |
Imp3 |
IMP3, U3 small nucleolar ribonucleoprotein |
increases expression |
ISO |
Buspirone results in increased expression of IMP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:56,937,500...56,938,398
Ensembl chr 9:56,937,475...56,938,398
|
|
G |
Inhba |
inhibin beta-A |
decreases expression |
ISO |
Buspirone results in decreased expression of INHBA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:16,004,256...16,031,609
Ensembl chr13:16,011,851...16,031,621
|
|
G |
Ip6k1 |
inositol hexaphosphate kinase 1 |
increases expression |
ISO |
Buspirone results in increased expression of IP6K1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:108,002,648...108,048,782
Ensembl chr 9:108,002,501...108,048,782
|
|
G |
Ipo9 |
importin 9 |
decreases expression |
ISO |
Buspirone results in decreased expression of IPO9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:135,382,312...135,430,499
Ensembl chr 1:135,382,312...135,430,499
|
|
G |
Irf1 |
interferon regulatory factor 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of IRF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:53,770,014...53,778,374
Ensembl chr11:53,770,014...53,778,374
|
|
G |
Irf7 |
interferon regulatory factor 7 |
decreases expression |
ISO |
Buspirone results in decreased expression of IRF7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:141,263,183...141,266,499
Ensembl chr 7:141,262,706...141,266,481
|
|
G |
Irgm1 |
immunity-related GTPase family M member 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of IRGM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:48,865,245...48,871,420
Ensembl chr11:48,861,968...48,871,683
|
|
G |
Itga6 |
integrin alpha 6 |
decreases expression |
ISO |
Buspirone results in decreased expression of ITGA6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:71,786,886...71,858,427
Ensembl chr 2:71,745,616...71,858,416
|
|
G |
Itgb2 |
integrin beta 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of ITGB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:77,530,329...77,565,708
Ensembl chr10:77,530,252...77,565,708
|
|
G |
Jak1 |
Janus kinase 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of JAK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:101,151,974...101,265,282
Ensembl chr 4:101,152,367...101,265,282
|
|
G |
Jam2 |
junction adhesion molecule 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of JAM2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:84,774,123...84,826,380
Ensembl chr16:84,774,123...84,825,928
|
|
G |
Jpt2 |
Jupiter microtubule associated homolog 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of JPT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:24,942,470...24,960,623
Ensembl chr17:24,937,419...24,960,689
|
|
G |
Jun |
jun proto-oncogene |
decreases expression |
ISO |
Buspirone results in decreased expression of JUN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:95,049,036...95,052,222
Ensembl chr 4:95,049,034...95,052,222
|
|
G |
Jup |
junction plakoglobin |
decreases expression |
ISO |
Buspirone results in decreased expression of JUP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:100,368,856...100,397,839
Ensembl chr11:100,368,958...100,397,763
|
|
G |
Kctd5 |
potassium channel tetramerisation domain containing 5 |
increases expression |
ISO |
Buspirone results in increased expression of KCTD5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:24,047,720...24,073,485
Ensembl chr17:24,047,734...24,073,485
|
|
G |
Khdrbs1 |
KH domain containing, RNA binding, signal transduction associated 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of KHDRBS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:129,702,380...129,743,878
Ensembl chr 4:129,703,164...129,742,303
|
|
G |
Klf15 |
Kruppel-like factor 15 |
increases expression |
ISO |
Buspirone results in increased expression of KLF15 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:90,461,043...90,491,803
Ensembl chr 6:90,462,576...90,475,238
|
|
G |
Klf9 |
Kruppel-like factor 9 |
increases expression |
ISO |
Buspirone results in increased expression of KLF9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:23,141,226...23,168,129
Ensembl chr19:23,141,226...23,168,134
|
|
G |
Klhl24 |
kelch-like 24 |
increases expression |
ISO |
Buspirone results in increased expression of KLHL24 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:20,097,553...20,129,226
Ensembl chr16:20,097,542...20,129,221
|
|
G |
Kpna2 |
karyopherin (importin) alpha 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of KPNA2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:106,988,629...106,999,525
Ensembl chr11:106,988,629...106,999,541
|
|
G |
Kpnb1 |
karyopherin (importin) beta 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of KPNB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:97,159,710...97,187,892
Ensembl chr11:97,159,714...97,187,881
|
|
G |
Krt18 |
keratin 18 |
decreases expression |
ISO |
Buspirone results in decreased expression of KRT18 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:102,028,216...102,032,026
Ensembl chr15:102,028,180...102,032,027
|
|
G |
Kyat1 |
kynurenine aminotransferase 1 |
increases expression |
ISO |
Buspirone results in increased expression of KYAT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:30,185,124...30,206,295
Ensembl chr 2:30,185,124...30,205,847
|
|
G |
Kyat3 |
kynurenine aminotransferase 3 |
increases expression |
ISO |
Buspirone results in increased expression of KYAT3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:142,701,019...142,744,911
Ensembl chr 3:142,701,051...142,746,870
|
|
G |
Lactb |
lactamase, beta |
decreases expression |
ISO |
Buspirone results in decreased expression of LACTB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:66,955,382...66,975,484
Ensembl chr 9:66,955,388...66,975,484
|
|
G |
Lamtor2 |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 |
increases expression |
ISO |
Buspirone results in increased expression of LAMTOR2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:88,549,819...88,552,951
Ensembl chr 3:88,549,819...88,553,074
|
|
G |
Lbp |
lipopolysaccharide binding protein |
increases expression |
ISO |
Buspirone results in increased expression of LBP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:158,306,493...158,332,852
Ensembl chr 2:158,306,493...158,332,852
|
|
G |
Lcmt1 |
leucine carboxyl methyltransferase 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of LCMT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:123,377,803...123,430,358
Ensembl chr 7:123,369,784...123,430,358
|
|
G |
Lcp1 |
lymphocyte cytosolic protein 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of LCP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:75,131,105...75,230,842
Ensembl chr14:75,131,101...75,230,842
|
|
G |
Leprotl1 |
leptin receptor overlapping transcript-like 1 |
increases expression |
ISO |
Buspirone results in increased expression of LEPROTL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:34,135,572...34,146,739
Ensembl chr 8:34,135,572...34,147,033
|
|
G |
Letm1 |
leucine zipper-EF-hand containing transmembrane protein 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of LETM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:33,739,673...33,782,717
Ensembl chr 5:33,739,673...33,782,817
|
|
G |
Lgals3 |
lectin, galactose binding, soluble 3 |
decreases expression |
ISO |
Buspirone results in decreased expression of LGALS3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:47,373,860...47,386,167
Ensembl chr14:47,367,751...47,386,160
|
|
G |
Lgals9 |
lectin, galactose binding, soluble 9 |
decreases expression |
ISO |
Buspirone results in decreased expression of LGALS9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:78,962,979...78,984,924
Ensembl chr11:78,962,974...78,984,946
|
|
G |
Lgalsl |
lectin, galactoside binding-like |
decreases expression |
ISO |
Buspirone results in decreased expression of LGALSL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:20,823,355...20,831,916
Ensembl chr11:20,823,576...20,831,056
|
|
G |
Lgmn |
legumain |
decreases expression |
ISO |
Buspirone results in decreased expression of LGMN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:102,394,082...102,439,728
Ensembl chr12:102,394,084...102,439,813
|
|
G |
Lipc |
lipase, hepatic |
decreases expression |
ISO |
Buspirone results in decreased expression of LIPC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:70,798,128...70,952,221
Ensembl chr 9:70,798,128...70,952,226
|
|
G |
Lman1 |
lectin, mannose-binding, 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of LMAN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:65,980,739...66,002,635
Ensembl chr18:65,980,738...66,022,580
|
|
G |
Lrat |
lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase) |
decreases expression |
ISO |
Buspirone results in decreased expression of LRAT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:82,892,582...82,903,974
Ensembl chr 3:82,892,579...82,903,973
|
|
G |
Lrp11 |
low density lipoprotein receptor-related protein 11 |
increases expression |
ISO |
Buspirone results in increased expression of LRP11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:7,589,817...7,624,768
Ensembl chr10:7,589,800...7,625,483
|
|
G |
Lrrc59 |
leucine rich repeat containing 59 |
decreases expression |
ISO |
Buspirone results in decreased expression of LRRC59 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:94,629,777...94,645,223
Ensembl chr11:94,629,767...94,645,216
|
|
G |
Lsm6 |
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated |
decreases expression |
ISO |
Buspirone results in decreased expression of LSM6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:78,804,868...78,821,152
Ensembl chr 8:78,804,865...78,821,140
|
|
G |
Lta4h |
leukotriene A4 hydrolase |
decreases expression |
ISO |
Buspirone results in decreased expression of LTA4H mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:93,453,396...93,484,896
Ensembl chr10:93,453,411...93,484,875
|
|
G |
Ly6e |
lymphocyte antigen 6 complex, locus E |
decreases expression |
ISO |
Buspirone results in decreased expression of LY6E mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:74,955,025...74,959,904
Ensembl chr15:74,955,051...74,959,905
|
|
G |
Lyve1 |
lymphatic vessel endothelial hyaluronan receptor 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of LYVE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:110,850,607...110,862,953
Ensembl chr 7:110,850,607...110,863,239
|
|
G |
Lyz2 |
lysozyme 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of LYZ2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:117,277,541...117,282,272
Ensembl chr10:117,277,331...117,282,321
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
increases expression |
ISO |
Buspirone results in increased expression of MAP1LC3B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:121,590,438...121,598,760
Ensembl chr 8:121,590,361...121,598,760
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
decreases expression |
ISO |
Buspirone results in decreased expression of MAPK9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:49,846,728...49,886,421
Ensembl chr11:49,846,751...49,886,421
|
|
G |
Mapre1 |
microtubule-associated protein, RP/EB family, member 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of MAPRE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:153,741,287...153,773,317
Ensembl chr 2:153,741,274...153,773,310
|
|
G |
Marchf2 |
membrane associated ring-CH-type finger 2 |
increases expression |
ISO |
Buspirone results in increased expression of MARCHF2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:33,685,692...33,718,677
Ensembl chr17:33,685,692...33,718,670
|
|
G |
Marchf6 |
membrane associated ring-CH-type finger 6 |
increases expression |
ISO |
Buspirone results in increased expression of MARCHF6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:31,455,899...31,531,082
Ensembl chr15:31,455,891...31,531,053
|
|
G |
Marcksl1 |
MARCKS-like 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of MARCKSL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:129,513,581...129,515,981
Ensembl chr 4:129,513,581...129,515,985
|
|
G |
Marf1 |
meiosis regulator and mRNA stability 1 |
increases expression |
ISO |
Buspirone results in increased expression of MARF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:14,109,166...14,159,278
Ensembl chr16:14,109,173...14,163,351
|
|
G |
Mat1a |
methionine adenosyltransferase I, alpha |
increases expression |
ISO |
Buspirone results in increased expression of MAT1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:41,105,012...41,124,428
Ensembl chr14:41,105,035...41,124,412
|
|
G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of MBL2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:30,232,906...30,239,687
Ensembl chr19:30,232,942...30,239,687
|
|
G |
Mcm7 |
minichromosome maintenance complex component 7 |
decreases expression |
ISO |
Buspirone results in decreased expression of MCM7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:138,164,583...138,172,111
Ensembl chr 5:138,164,583...138,172,422
|
|
G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
decreases expression |
ISO |
Buspirone results in decreased expression of ME1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:86,581,363...86,695,914
Ensembl chr 9:86,581,371...86,695,953
|
|
G |
Mettl23 |
methyltransferase like 23 |
increases expression |
ISO |
Buspirone results in increased expression of METTL23 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:116,843,515...116,849,740
Ensembl chr11:116,843,278...116,854,263
|
|
G |
Mettl7a1 |
methyltransferase like 7A1 |
increases expression |
ISO |
Buspirone results in increased expression of METTL7A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:100,304,145...100,330,001
Ensembl chr15:100,304,140...100,328,662
|
|
G |
Mfsd2a |
major facilitator superfamily domain containing 2A |
increases expression |
ISO |
Buspirone results in increased expression of MFSD2A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:122,946,850...122,961,194
Ensembl chr 4:122,946,850...122,961,188
|
|
G |
Mgll |
monoglyceride lipase |
decreases expression |
ISO |
Buspirone results in decreased expression of MGLL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:88,724,412...88,828,360
Ensembl chr 6:88,724,412...88,828,360
|
|
G |
Mid1ip1 |
Mid1 interacting protein 1 (gastrulation specific G12-like (zebrafish)) |
decreases expression |
ISO |
Buspirone results in decreased expression of MID1IP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:10,717,365...10,719,702
Ensembl chr X:10,715,013...10,719,690
|
|
G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
decreases expression |
ISO |
Buspirone results in decreased expression of MIF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:75,859,353...75,860,277
Ensembl chr10:75,859,353...75,860,240
|
|
G |
Morf4l2 |
mortality factor 4 like 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of MORF4L2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:136,732,942...136,743,686
Ensembl chr X:136,732,942...136,743,690
|
|
G |
Mrpl1 |
mitochondrial ribosomal protein L1 |
decreases expression |
ISO |
Buspirone results in decreased expression of MRPL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:96,209,498...96,266,727
Ensembl chr 5:96,209,493...96,266,727
|
|
G |
Mrpl15 |
mitochondrial ribosomal protein L15 |
decreases expression |
ISO |
Buspirone results in decreased expression of MRPL15 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:4,773,198...4,785,750
Ensembl chr 1:4,773,206...4,785,739
|
|
G |
Mrpl34 |
mitochondrial ribosomal protein L34 |
increases expression |
ISO |
Buspirone results in increased expression of MRPL34 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:71,464,926...71,465,753
Ensembl chr 8:71,464,959...71,465,747
|
|
G |
Mrps22 |
mitochondrial ribosomal protein S22 |
decreases expression |
ISO |
Buspirone results in decreased expression of MRPS22 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:98,588,730...98,601,679
Ensembl chr 9:98,588,730...98,601,660
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
ISO |
Buspirone results in increased expression of MT1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:94,178,883...94,180,327
Ensembl chr 8:94,179,082...94,180,327
|
|
G |
Mtarc2 |
mitochondrial amidoxime reducing component 2 |
increases expression |
ISO |
Buspirone results in increased expression of MTARC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:184,813,066...184,846,451
Ensembl chr 1:184,813,068...184,846,451
|
|
G |
Mthfd1 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent), methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthase |
decreases expression |
ISO |
Buspirone results in decreased expression of MTHFD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:76,254,406...76,319,820
Ensembl chr12:76,255,298...76,319,803
|
|
G |
Mtss1 |
MTSS I-BAR domain containing 1 |
increases expression |
ISO |
Buspirone results in increased expression of MTSS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:58,941,234...59,083,956
Ensembl chr15:58,941,234...59,082,005
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
decreases expression |
ISO |
Buspirone results in decreased expression of MTTP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:138,089,855...138,143,418
Ensembl chr 3:138,089,854...138,144,968
|
|
G |
Mug1 |
murinoglobulin 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of MUG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:121,838,496...121,889,057
Ensembl chr 6:121,838,541...121,889,057
|
|
G |
Myd88 |
myeloid differentiation primary response gene 88 |
increases expression |
ISO |
Buspirone results in increased expression of MYD88 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:119,335,934...119,340,018
Ensembl chr 9:119,335,934...119,341,411
|
|
G |
Myh9 |
myosin, heavy polypeptide 9, non-muscle |
decreases expression |
ISO |
Buspirone results in decreased expression of MYH9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:77,760,585...77,842,175
Ensembl chr15:77,760,587...77,842,175
|
|
G |
Naa15 |
N(alpha)-acetyltransferase 15, NatA auxiliary subunit |
decreases expression |
ISO |
Buspirone results in decreased expression of NAA15 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:51,416,016...51,475,985
Ensembl chr 3:51,415,148...51,476,507
|
|
G |
Nans |
N-acetylneuraminic acid synthase (sialic acid synthase) |
decreases expression |
ISO |
Buspirone results in decreased expression of NANS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:46,489,329...46,503,438
Ensembl chr 4:46,489,248...46,503,632
|
|
G |
Ndfip1 |
Nedd4 family interacting protein 1 |
increases expression |
ISO |
Buspirone results in increased expression of NDFIP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:38,418,907...38,465,197
Ensembl chr18:38,410,396...38,465,303
|
|
G |
Ndufa6 |
NADH:ubiquinone oxidoreductase subunit A6 |
increases expression |
ISO |
Buspirone results in increased expression of NDUFA6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:82,350,139...82,354,291
Ensembl chr15:82,350,140...82,354,322
|
|
G |
Ndufa7 |
NADH:ubiquinone oxidoreductase subunit A7 |
increases expression |
ISO |
Buspirone results in increased expression of NDUFA7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:33,824,572...33,838,316
Ensembl chr17:33,824,572...33,838,317
|
|
G |
Ndufb2 |
NADH:ubiquinone oxidoreductase subunit B2 |
increases expression |
ISO |
Buspirone results in increased expression of NDUFB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:39,592,565...39,599,843
Ensembl chr 6:39,592,574...39,603,382
|
|
G |
Nectin3 |
nectin cell adhesion molecule 3 |
decreases expression |
ISO |
Buspirone results in decreased expression of NECTIN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:46,387,665...46,498,535
Ensembl chr16:46,387,706...46,498,525
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of NFE2L2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:75,675,513...75,704,663
Ensembl chr 2:75,675,513...75,704,641
|
|
G |
Nhp2 |
NHP2 ribonucleoprotein |
decreases expression |
ISO |
Buspirone results in decreased expression of NHP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:51,619,773...51,623,718
Ensembl chr11:51,619,735...51,623,714
|
|
G |
Nid1 |
nidogen 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of NID1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:13,437,602...13,512,275
Ensembl chr13:13,437,551...13,512,269
|
|
G |
Nit1 |
nitrilase 1 |
increases expression |
ISO |
Buspirone results in increased expression of NIT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:171,340,571...171,345,656
Ensembl chr 1:171,338,008...171,345,646
|
|
G |
Nln |
neurolysin (metallopeptidase M3 family) |
decreases expression |
ISO |
Buspirone results in decreased expression of NLN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:104,023,050...104,109,673
Ensembl chr13:104,023,057...104,109,614
|
|
G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of NME1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:93,958,925...93,968,272
Ensembl chr11:93,956,979...93,968,521
|
|
G |
Nme3 |
NME/NM23 nucleoside diphosphate kinase 3 |
increases expression |
ISO |
Buspirone results in increased expression of NME3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:24,896,500...24,897,531
Ensembl chr17:24,896,500...24,897,522
|
|
G |
Nop53 |
NOP53 ribosome biogenesis factor |
increases expression |
ISO |
Buspirone results in increased expression of NOP53 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:15,937,835...15,946,108
Ensembl chr 7:15,936,183...15,946,074
|
|
G |
Nop58 |
NOP58 ribonucleoprotein |
decreases expression |
ISO |
Buspirone results in decreased expression of NOL5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:59,684,961...59,711,510
Ensembl chr 1:59,684,971...59,719,044
|
|
G |
Notch2 |
notch 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of NOTCH2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:98,013,538...98,150,367
Ensembl chr 3:98,013,527...98,150,361
|
|
G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
increases expression |
ISO |
Buspirone results in increased expression of NR1D2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:18,204,056...18,239,106
Ensembl chr14:18,204,054...18,239,127
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases expression |
ISO |
Buspirone results in increased expression of NR1I2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:38,248,349...38,294,849
Ensembl chr16:38,248,323...38,294,824
|
|
G |
Nrbp2 |
nuclear receptor binding protein 2 |
increases expression |
ISO |
Buspirone results in increased expression of NRBP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:76,085,515...76,091,690
Ensembl chr15:76,085,518...76,091,627
|
|
G |
Nrep |
neuronal regeneration related protein |
decreases expression |
ISO |
Buspirone results in decreased expression of NREP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:33,437,019...33,464,365
Ensembl chr18:33,437,019...33,464,029
|
|
G |
Nsdhl |
NAD(P) dependent steroid dehydrogenase-like |
decreases expression |
ISO |
Buspirone results in decreased expression of NSDHL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:72,918,521...72,958,528
Ensembl chr X:72,918,557...72,958,514
|
|
G |
Nt5e |
5' nucleotidase, ecto |
decreases expression |
ISO |
Buspirone results in decreased expression of NT5E mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:88,327,609...88,372,089
Ensembl chr 9:88,327,197...88,372,092
|
|
G |
Ntpcr |
nucleoside-triphosphatase, cancer-related |
increases expression |
ISO |
Buspirone results in increased expression of NTPCR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:125,729,975...125,748,235
Ensembl chr 8:125,729,963...125,748,235
|
|
G |
Nucb2 |
nucleobindin 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of NUCB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:116,504,352...116,540,588
Ensembl chr 7:116,504,369...116,540,584
|
|
G |
Nudt4 |
nudix (nucleoside diphosphate linked moiety X)-type motif 4 |
increases expression |
ISO |
Buspirone results in increased expression of NUDT4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:95,547,007...95,564,146
Ensembl chr10:95,547,007...95,564,146
|
|
G |
Ola1 |
Obg-like ATPase 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of OLA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:73,092,801...73,214,447
Ensembl chr 2:73,092,801...73,218,924
|
|
G |
Oplah |
5-oxoprolinase (ATP-hydrolysing) |
increases expression |
ISO |
Buspirone results in increased expression of OPLAH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:76,296,603...76,331,181
Ensembl chr15:76,296,601...76,328,015
|
|
G |
Osbpl1a |
oxysterol binding protein-like 1A |
decreases expression |
ISO |
Buspirone results in decreased expression of OSBPL1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:12,753,898...12,941,871
Ensembl chr18:12,755,314...12,941,841
|
|
G |
Pald1 |
phosphatase domain containing, paladin 1 |
increases expression |
ISO |
Buspirone results in increased expression of PALD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:61,319,656...61,383,546
Ensembl chr10:61,319,656...61,383,530
|
|
G |
Palmd |
palmdelphin |
decreases expression |
ISO |
Buspirone results in decreased expression of PALMD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:116,918,262...116,968,952
Ensembl chr 3:116,918,258...116,968,987
|
|
G |
Paqr9 |
progestin and adipoQ receptor family member IX |
decreases expression |
ISO |
Buspirone results in decreased expression of PAQR9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:95,559,634...95,568,022
Ensembl chr 9:95,559,657...95,568,023
|
|
G |
Parp14 |
poly (ADP-ribose) polymerase family, member 14 |
decreases expression |
ISO |
Buspirone results in decreased expression of PARP14 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:35,831,892...35,871,518
Ensembl chr16:35,832,874...35,871,544
|
|
G |
Pbld1 |
phenazine biosynthesis-like protein domain containing 1 |
increases expression |
ISO |
Buspirone results in increased expression of PBLD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:63,060,625...63,077,964
Ensembl chr10:63,060,162...63,077,962
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
ISO |
Buspirone results in decreased expression of PCNA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:132,249,286...132,253,180
Ensembl chr 2:132,249,162...132,253,314
|
|
G |
Pctp |
phosphatidylcholine transfer protein |
decreases expression |
ISO |
Buspirone results in decreased expression of PCTP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:89,982,544...90,002,894
Ensembl chr11:89,982,665...90,002,894
|
|
G |
Pcyt1a |
phosphate cytidylyltransferase 1, choline, alpha isoform |
increases expression |
ISO |
Buspirone results in increased expression of PCYT1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:32,430,921...32,475,065
Ensembl chr16:32,430,921...32,475,070
|
|
G |
Pdcd4 |
programmed cell death 4 |
decreases expression |
ISO |
Buspirone results in decreased expression of PDCD4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:53,892,231...53,937,592
Ensembl chr19:53,892,231...53,929,860
|
|
G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
decreases expression |
ISO |
Buspirone results in decreased expression of PDE4B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:102,087,332...102,607,275
Ensembl chr 4:102,087,543...102,607,259
|
|
G |
Pdia5 |
protein disulfide isomerase associated 5 |
decreases expression |
ISO |
Buspirone results in decreased expression of PDIA5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:35,397,308...35,490,919
Ensembl chr16:35,397,312...35,490,873
|
|
G |
Pdia6 |
protein disulfide isomerase associated 6 |
decreases expression |
ISO |
Buspirone results in decreased expression of PDIA6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:17,266,589...17,284,785
Ensembl chr12:17,266,545...17,284,770
|
|
G |
Pdlim1 |
PDZ and LIM domain 1 (elfin) |
decreases expression |
ISO |
Buspirone results in decreased expression of PDLIM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:40,222,239...40,271,616
Ensembl chr19:40,221,173...40,271,842
|
|
G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
increases expression |
ISO |
Buspirone results in increased expression of PEX11A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:79,735,957...79,743,131
Ensembl chr 7:79,735,957...79,743,131
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
decreases expression |
ISO |
Buspirone results in decreased expression of PGD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:149,149,991...149,166,705
Ensembl chr 4:149,149,991...149,166,771
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of PGK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:106,187,100...106,203,699
Ensembl chr X:106,187,100...106,203,699
|
|
G |
Phf11d |
PHD finger protein 11D |
decreases expression |
ISO |
Buspirone results in decreased expression of PHF11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:59,347,407...59,365,490
Ensembl chr14:59,347,407...59,365,470
|
|
G |
Phyhd1 |
phytanoyl-CoA dioxygenase domain containing 1 |
increases expression |
ISO |
Buspirone results in increased expression of PHYHD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:30,266,203...30,282,149
Ensembl chr 2:30,266,203...30,282,149
|
|
G |
Pim3 |
proviral integration site 3 |
increases expression |
ISO |
Buspirone results in increased expression of PIM3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:88,862,194...88,865,726
Ensembl chr15:88,862,186...88,865,726
|
|
G |
Pink1 |
PTEN induced putative kinase 1 |
increases expression |
ISO |
Buspirone results in increased expression of PINK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:138,313,409...138,326,296
Ensembl chr 4:138,313,409...138,326,307
|
|
G |
Pklr |
pyruvate kinase liver and red blood cell |
decreases expression |
ISO |
Buspirone results in decreased expression of PKLR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:89,136,122...89,146,815
Ensembl chr 3:89,136,142...89,146,784
|
|
G |
Pla2g12a |
phospholipase A2, group XIIA |
increases expression |
ISO |
Buspirone results in increased expression of PLA2G12A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:129,878,606...129,895,825
Ensembl chr 3:129,878,606...129,895,825
|
|
G |
Plcb1 |
phospholipase C, beta 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of PLCB1 mRNA; Buspirone results in decreased expression of PLCB1 protein |
CTD |
PMID:12527476 |
|
NCBI chr 2:134,786,164...135,475,258
Ensembl chr 2:134,786,067...135,475,258
|
|
G |
Plin2 |
perilipin 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of PLIN2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:86,626,910...86,670,217
Ensembl chr 4:86,648,386...86,670,060
|
|
G |
Plin3 |
perilipin 3 |
decreases expression |
ISO |
Buspirone results in decreased expression of PLIN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:56,278,962...56,290,511
Ensembl chr17:56,277,476...56,292,873
|
|
G |
Plpp3 |
phospholipid phosphatase 3 |
increases expression |
ISO |
Buspirone results in increased expression of PLPP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:105,157,347...105,232,767
Ensembl chr 4:105,157,347...105,232,764
|
|
G |
Plxna2 |
plexin A2 |
decreases expression |
ISO |
Buspirone results in decreased expression of PLXNA2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:194,619,791...194,816,869
Ensembl chr 1:194,618,218...194,816,869
|
|
G |
Pnpla2 |
patatin-like phospholipase domain containing 2 |
increases expression |
ISO |
Buspirone results in increased expression of PNPLA2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:141,455,188...141,460,743
Ensembl chr 7:141,455,198...141,460,743
|
|
G |
Pnpla7 |
patatin-like phospholipase domain containing 7 |
increases expression |
ISO |
Buspirone results in increased expression of PNPLA7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:24,975,990...25,054,072
Ensembl chr 2:24,976,033...25,054,057
|
|
G |
Pnpla8 |
patatin-like phospholipase domain containing 8 |
increases expression |
ISO |
Buspirone results in increased expression of PNPLA8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:44,269,132...44,315,936
Ensembl chr12:44,221,370...44,322,532
|
|
G |
Pold4 |
polymerase (DNA-directed), delta 4 |
increases expression |
ISO |
Buspirone results in increased expression of POLD4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:4,231,893...4,233,634
Ensembl chr19:4,231,899...4,233,634
|
|
G |
Polg2 |
polymerase (DNA directed), gamma 2, accessory subunit |
increases expression |
ISO |
Buspirone results in increased expression of POLG2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:106,768,204...106,779,537
Ensembl chr11:106,768,253...106,779,537
|
|
G |
Polr2b |
polymerase (RNA) II (DNA directed) polypeptide B |
decreases expression |
ISO |
Buspirone results in decreased expression of POLR2B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:77,310,484...77,349,328
Ensembl chr 5:77,310,147...77,349,324
|
|
G |
Pomc |
pro-opiomelanocortin-alpha |
increases expression multiple interactions |
ISO |
Buspirone results in increased expression of POMC protein Imipramine inhibits the reaction [Buspirone results in increased expression of POMC protein] |
CTD |
PMID:19762159 |
|
NCBI chr12:3,954,945...3,960,643
Ensembl chr12:3,954,951...3,960,642
|
|
G |
Por |
cytochrome p450 oxidoreductase |
increases expression |
ISO |
Buspirone results in increased expression of POR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:135,670,040...135,735,326
Ensembl chr 5:135,670,033...135,735,326
|
|
G |
Ppa1 |
pyrophosphatase (inorganic) 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of PPA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:61,648,621...61,674,165
Ensembl chr10:61,648,552...61,674,168
|
|
G |
Ppcs |
phosphopantothenoylcysteine synthetase |
increases expression |
ISO |
Buspirone results in increased expression of PPCS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:119,418,527...119,422,440
Ensembl chr 4:119,418,530...119,422,420
|
|
G |
Ppox |
protoporphyrinogen oxidase |
decreases expression |
ISO |
Buspirone results in decreased expression of PPOX mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:171,276,991...171,281,193
Ensembl chr 1:171,275,990...171,281,186
|
|
G |
Ppp1r14a |
protein phosphatase 1, regulatory inhibitor subunit 14A |
decreases expression |
ISO |
Buspirone results in decreased expression of PPP1R14A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:29,289,320...29,293,390
Ensembl chr 7:29,289,308...29,293,801
|
|
G |
Ppp1r21 |
protein phosphatase 1, regulatory subunit 21 |
decreases expression |
ISO |
Buspirone results in decreased expression of PPP1R21 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:88,530,124...88,588,367
Ensembl chr17:88,530,118...88,588,367
|
|
G |
Prc1 |
protein regulator of cytokinesis 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of PRC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:80,294,445...80,316,259
Ensembl chr 7:80,294,450...80,316,259
|
|
G |
Prdx5 |
peroxiredoxin 5 |
increases expression |
ISO |
Buspirone results in increased expression of PRDX5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:6,906,697...6,910,106
Ensembl chr19:6,906,697...6,910,106
|
|
G |
Prkaca |
protein kinase, cAMP dependent, catalytic, alpha |
decreases expression |
ISO |
Buspirone results in decreased expression of PRKACA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:83,972,978...83,996,444
Ensembl chr 8:83,972,993...83,996,443
|
|
G |
Prl |
prolactin |
increases secretion multiple interactions increases expression |
ISO |
Buspirone results in increased secretion of PRL protein Pindolol inhibits the reaction [Buspirone results in increased secretion of PRL protein] Buspirone results in increased expression of PRL protein |
CTD |
PMID:18194152 PMID:19762159 |
|
NCBI chr13:27,057,570...27,065,204
Ensembl chr13:27,057,570...27,065,205
|
|
G |
Proser2 |
proline and serine rich 2 |
increases expression |
ISO |
Buspirone results in increased expression of PROSER2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:6,098,493...6,130,291
Ensembl chr 2:6,097,607...6,130,211
|
|
G |
Prr13 |
proline rich 13 |
decreases expression |
ISO |
Buspirone results in decreased expression of PRR13 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:102,459,170...102,462,806
Ensembl chr15:102,459,028...102,462,806
|
|
G |
Prss23 |
protease, serine 23 |
decreases expression |
ISO |
Buspirone results in decreased expression of PRSS23 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:89,507,783...89,527,187
Ensembl chr 7:89,507,783...89,527,187
|
|
G |
Psenen |
presenilin enhancer gamma secretase subunit |
increases expression |
ISO |
Buspirone results in increased expression of PSENEN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:30,561,865...30,563,627
Ensembl chr 7:30,561,863...30,563,627
|
|
G |
Psmb10 |
proteasome (prosome, macropain) subunit, beta type 10 |
decreases expression |
ISO |
Buspirone results in decreased expression of PSMB10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:105,935,728...105,938,392
Ensembl chr 8:105,935,735...105,938,444
|
|
G |
Psmb3 |
proteasome (prosome, macropain) subunit, beta type 3 |
increases expression |
ISO |
Buspirone results in increased expression of PSMB3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:97,703,434...97,713,500
Ensembl chr11:97,703,399...97,713,500
|
|
G |
Psmb4 |
proteasome (prosome, macropain) subunit, beta type 4 |
increases expression |
ISO |
Buspirone results in increased expression of PSMB4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:94,884,324...94,886,958
Ensembl chr 3:94,884,093...94,886,961
|
|
G |
Psmb8 |
proteasome (prosome, macropain) subunit, beta type 8 (large multifunctional peptidase 7) |
decreases expression |
ISO |
Buspirone results in decreased expression of PSMB8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:34,198,195...34,201,454
Ensembl chr17:34,197,721...34,201,454
|
|
G |
Psmb9 |
proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2) |
decreases expression |
ISO |
Buspirone results in decreased expression of PSMB9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:34,182,030...34,187,330
Ensembl chr17:34,181,987...34,187,764
|
|
G |
Ptma |
prothymosin alpha |
decreases expression |
ISO |
Buspirone results in decreased expression of PTMA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:86,526,557...86,530,712
Ensembl chr 1:86,526,726...86,530,712
|
|
G |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
decreases expression |
ISO |
Buspirone results in decreased expression of PTPRF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:118,208,213...118,291,405
Ensembl chr 4:118,208,213...118,291,405
|
|
G |
Pttg1 |
pituitary tumor-transforming gene 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of PTTG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:43,420,244...43,427,463
Ensembl chr11:43,420,250...43,426,251
|
|
G |
Pygl |
liver glycogen phosphorylase |
decreases expression |
ISO |
Buspirone results in decreased expression of PYGL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:70,190,815...70,227,683
Ensembl chr12:70,190,811...70,231,488
|
|
G |
R3hdm2 |
R3H domain containing 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of R3HDM2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:127,380,332...127,499,384
Ensembl chr10:127,380,327...127,499,384
|
|
G |
Rab17 |
RAB17, member RAS oncogene family |
increases expression |
ISO |
Buspirone results in increased expression of RAB17 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:90,958,133...90,969,673
Ensembl chr 1:90,958,133...90,969,661
|
|
G |
Rab29 |
RAB29, member RAS oncogene family |
increases expression |
ISO |
Buspirone results in increased expression of RAB29 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:131,867,210...131,872,887
Ensembl chr 1:131,867,224...131,872,887
|
|
G |
Rab30 |
RAB30, member RAS oncogene family |
increases expression |
ISO |
Buspirone results in increased expression of RAB30 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:92,741,637...92,844,535
Ensembl chr 7:92,741,603...92,844,535
|
|
G |
Rab34 |
RAB34, member RAS oncogene family |
increases expression |
ISO |
Buspirone results in increased expression of RAB34 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:78,188,427...78,192,193
Ensembl chr11:78,188,430...78,192,193
|
|
G |
Rab38 |
RAB38, member RAS oncogene family |
decreases expression |
ISO |
Buspirone results in decreased expression of RAB38 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:88,430,273...88,491,572
Ensembl chr 7:88,430,273...88,491,572
|
|
G |
Rab5if |
RAB5 interacting factor |
increases expression |
ISO |
Buspirone results in increased expression of RAB5IF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:156,863,122...156,873,563
Ensembl chr 2:156,863,128...156,873,563
|
|
G |
Rab7 |
RAB7, member RAS oncogene family |
decreases expression |
ISO |
Buspirone results in decreased expression of RAB7A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:87,999,106...88,045,270
Ensembl chr 6:87,999,106...88,045,270
|
|
G |
Rabac1 |
Rab acceptor 1 (prenylated) |
increases expression |
ISO |
Buspirone results in increased expression of RABAC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:24,969,750...24,972,728
Ensembl chr 7:24,969,752...24,972,754
|
|
G |
Ran |
RAN, member RAS oncogene family |
decreases expression |
ISO |
Buspirone results in decreased expression of RAN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:129,020,156...129,024,322
Ensembl chr 5:129,020,069...129,024,323
|
|
G |
Rangap1 |
RAN GTPase activating protein 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of RANGAP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:81,704,248...81,730,798
Ensembl chr15:81,704,248...81,745,530
|
|
G |
Rapgef4 |
Rap guanine nucleotide exchange factor (GEF) 4 |
increases expression |
ISO |
Buspirone results in increased expression of RAPGEF4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:71,981,215...72,257,474
Ensembl chr 2:71,981,240...72,257,474
|
|
G |
Rarb |
retinoic acid receptor, beta |
decreases expression |
ISO |
Buspirone results in decreased expression of RARB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:16,430,839...17,082,331
Ensembl chr14:16,430,839...16,819,156
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of RB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:73,192,858...73,325,951
Ensembl chr14:73,183,673...73,325,822
|
|
G |
Rbfa |
ribosome binding factor A |
decreases expression |
ISO |
Buspirone results in decreased expression of RBFA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:80,192,264...80,200,619
Ensembl chr18:80,192,265...80,200,658
|
|
G |
Rcan1 |
regulator of calcineurin 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of RCAN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:92,391,951...92,466,169
Ensembl chr16:92,391,953...92,470,867
|
|
G |
Rcl1 |
RNA terminal phosphate cyclase-like 1 |
increases expression |
ISO |
Buspirone results in increased expression of RCL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:29,101,375...29,143,851
Ensembl chr19:29,101,375...29,143,929
|
|
G |
Rdh11 |
retinol dehydrogenase 11 |
decreases expression |
ISO |
Buspirone results in decreased expression of RDH11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:79,174,233...79,191,855
Ensembl chr12:79,174,337...79,192,293
|
|
G |
Retreg1 |
reticulophagy regulator 1 |
increases expression |
ISO |
Buspirone results in increased expression of RETREG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:25,843,298...25,973,696
Ensembl chr15:25,843,180...25,973,687
|
|
G |
Rex1bd |
required for excision 1-B domain containing |
increases expression |
ISO |
Buspirone results in increased expression of REX1BD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:70,504,295...70,506,752
Ensembl chr 8:70,504,292...70,506,752
|
|
G |
Rhob |
ras homolog family member B |
decreases expression |
ISO |
Buspirone results in decreased expression of RHOB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:8,497,661...8,500,009
Ensembl chr12:8,497,661...8,500,009
|
|
G |
Rnd2 |
Rho family GTPase 2 |
increases expression |
ISO |
Buspirone results in increased expression of RND2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:101,468,175...101,471,853
Ensembl chr11:101,464,999...101,471,853
|
|
G |
Rnf125 |
ring finger protein 125 |
decreases expression |
ISO |
Buspirone results in decreased expression of RNF125 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:20,944,615...20,987,359
Ensembl chr18:20,944,625...20,983,862
|
|
G |
Rnf139 |
ring finger protein 139 |
increases expression |
ISO |
Buspirone results in increased expression of RNF139 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:58,889,229...58,902,390
Ensembl chr15:58,889,229...58,907,057
|
|
G |
Rnf149 |
ring finger protein 149 |
increases expression |
ISO |
Buspirone results in increased expression of RNF149 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:39,551,294...39,577,439
Ensembl chr 1:39,551,296...39,577,405
|
|
G |
Rnf26 |
ring finger protein 26 |
decreases expression |
ISO |
Buspirone results in decreased expression of RNF26 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:44,110,781...44,113,051
Ensembl chr 9:44,095,631...44,113,517 Ensembl chr 9:44,095,631...44,113,517
|
|
G |
Rorc |
RAR-related orphan receptor gamma |
decreases expression |
ISO |
Buspirone results in decreased expression of RORC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:94,372,794...94,398,276
Ensembl chr 3:94,372,794...94,398,276
|
|
G |
Rpa1 |
replication protein A1 |
decreases expression |
ISO |
Buspirone results in decreased expression of RPA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:75,300,259...75,348,454
Ensembl chr11:75,298,166...75,348,324
|
|
G |
Rpa3 |
replication protein A3 |
decreases expression |
ISO |
Buspirone results in decreased expression of RPA3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:8,255,936...8,259,141
Ensembl chr 6:8,255,936...8,259,173
|
|
G |
Rpe |
ribulose-5-phosphate-3-epimerase |
decreases expression |
ISO |
Buspirone results in decreased expression of RPE mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:66,700,797...66,719,805
Ensembl chr 1:66,700,831...66,719,805
|
|
G |
Rpl7l1 |
ribosomal protein L7-like 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of RPL7L1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:46,773,907...46,782,656
Ensembl chr17:46,773,907...46,782,672
|
|
G |
Rpn1 |
ribophorin I |
decreases expression |
ISO |
Buspirone results in decreased expression of RPN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:88,084,473...88,105,304
Ensembl chr 6:88,084,482...88,105,304
|
|
G |
Rrm2 |
ribonucleotide reductase M2 |
decreases expression |
ISO |
Buspirone results in decreased expression of RRM2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:24,708,254...24,714,146
Ensembl chr12:24,708,241...24,714,146
|
|
G |
S100b |
S100 protein, beta polypeptide, neural |
decreases response to substance |
EXP |
S100B results in decreased susceptibility to Buspirone |
CTD |
PMID:12888777 |
|
NCBI chr10:76,253,836...76,261,319
Ensembl chr10:76,253,853...76,261,159
|
|
G |
Sae1 |
SUMO1 activating enzyme subunit 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of SAE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:16,320,236...16,387,896
Ensembl chr 7:16,320,234...16,387,806
|
|
G |
Sall1 |
spalt like transcription factor 1 |
increases expression |
ISO |
Buspirone results in increased expression of SALL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:89,027,242...89,044,162
Ensembl chr 8:89,027,235...89,044,162
|
|
G |
Sar1b |
secretion associated Ras related GTPase 1B |
increases expression |
ISO |
Buspirone results in increased expression of SAR1B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:51,763,663...51,791,953
Ensembl chr11:51,763,687...51,791,925
|
|
G |
Sat2 |
spermidine/spermine N1-acetyl transferase 2 |
increases expression |
ISO |
Buspirone results in increased expression of SAT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:69,621,996...69,624,032
Ensembl chr11:69,622,024...69,623,870
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of SCARB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:125,277,087...125,341,094
Ensembl chr 5:125,277,087...125,341,094
|
|
G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of SCD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:44,394,450...44,407,709
Ensembl chr19:44,394,455...44,407,879
|
|
G |
Scfd1 |
Sec1 family domain containing 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of SCFD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:51,377,513...51,450,104
Ensembl chr12:51,377,510...51,450,101
|
|
G |
Scly |
selenocysteine lyase |
decreases expression |
ISO |
Buspirone results in decreased expression of SCLY mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:91,298,295...91,321,080
Ensembl chr 1:91,298,338...91,321,075
|
|
G |
Sdc4 |
syndecan 4 |
increases expression |
ISO |
Buspirone results in increased expression of SDC4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:164,424,247...164,443,188
Ensembl chr 2:164,424,247...164,443,887
|
|
G |
Sdf2 |
stromal cell derived factor 2 |
increases expression |
ISO |
Buspirone results in increased expression of SDF2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:78,245,746...78,255,496
Ensembl chr11:78,245,746...78,255,496
|
|
G |
Sds |
serine dehydratase |
increases expression |
ISO |
Buspirone results in increased expression of SDS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:120,476,547...120,483,932
Ensembl chr 5:120,476,526...120,483,932
|
|
G |
Sec13 |
SEC13 homolog, nuclear pore and COPII coat complex component |
decreases expression |
ISO |
Buspirone results in decreased expression of SEC13 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:113,728,052...113,740,681
Ensembl chr 6:113,728,062...113,740,743
|
|
G |
Sec22b |
SEC22 homolog B, vesicle trafficking protein |
decreases expression |
ISO |
Buspirone results in decreased expression of SEC22B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:97,901,227...97,922,318
Ensembl chr 3:97,901,190...97,923,276
|
|
G |
Sec23b |
SEC23 homolog B, COPII coat complex component |
decreases expression |
ISO |
Buspirone results in decreased expression of SEC23B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:144,556,229...144,590,753
Ensembl chr 2:144,556,229...144,590,749
|
|
G |
Sec61a1 |
Sec61 alpha 1 subunit (S. cerevisiae) |
decreases expression |
ISO |
Buspirone results in decreased expression of SEC61A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:88,503,607...88,518,800
Ensembl chr 6:88,503,579...88,518,905
|
|
G |
Sec63 |
SEC63-like (S. cerevisiae) |
decreases expression |
ISO |
Buspirone results in decreased expression of SEC63 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:42,761,496...42,832,514
Ensembl chr10:42,761,496...42,832,514
|
|
G |
Secisbp2l |
SECIS binding protein 2-like |
decreases expression |
ISO |
Buspirone results in decreased expression of SECISBP2L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:125,736,986...125,782,870
Ensembl chr 2:125,736,986...125,782,870
|
|
G |
Septin10 |
septin 10 |
decreases expression |
ISO |
Buspirone results in decreased expression of SEPTIN10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:59,141,624...59,221,500
Ensembl chr10:59,141,627...59,221,847
|
|
G |
Septin7 |
septin 7 |
decreases expression |
ISO |
Buspirone results in decreased expression of SEPTIN7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:25,251,991...25,308,571
Ensembl chr 9:25,252,439...25,308,571
|
|
G |
Septin9 |
septin 9 |
decreases expression |
ISO |
Buspirone results in decreased expression of SEPTIN9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:117,199,661...117,362,325
Ensembl chr11:117,199,661...117,362,325
|
|
G |
Serpina11 |
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 |
increases expression |
ISO |
Buspirone results in increased expression of SERPINA11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:103,980,243...103,989,968
Ensembl chr12:103,980,243...103,989,957
|
|
G |
Serpina6 |
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
decreases expression |
ISO |
Buspirone results in decreased expression of SERPINA6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:103,646,630...103,657,218
Ensembl chr12:103,646,630...103,657,212
|
|
G |
Serpinb9 |
serine (or cysteine) peptidase inhibitor, clade B, member 9 |
decreases expression |
ISO |
Buspirone results in decreased expression of SERPINB9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:32,997,061...33,017,955
Ensembl chr13:33,003,250...33,017,957
|
|
G |
Sf3a3 |
splicing factor 3a, subunit 3 |
decreases expression |
ISO |
Buspirone results in decreased expression of SF3A3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:124,714,861...124,732,423
Ensembl chr 4:124,714,776...124,732,460
|
|
G |
Sfpq |
splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated) |
decreases expression |
ISO |
Buspirone results in decreased expression of SFPQ mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:127,020,716...127,051,101
Ensembl chr 4:127,021,324...127,037,013
|
|
G |
Sft2d2 |
SFT2 domain containing 2 |
increases expression |
ISO |
Buspirone results in increased expression of SFT2D2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:165,174,341...165,194,522
Ensembl chr 1:165,174,337...165,194,438
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of SGK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:21,882,184...21,999,903
Ensembl chr10:21,882,184...21,999,903
|
|
G |
Sgpp1 |
sphingosine-1-phosphate phosphatase 1 |
increases expression |
ISO |
Buspirone results in increased expression of SGPP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:75,714,248...75,735,729
Ensembl chr12:75,714,249...75,735,729
|
|
G |
Sh3bgrl3 |
SH3 domain binding glutamic acid-rich protein-like 3 |
decreases expression |
ISO |
Buspirone results in decreased expression of SH3BGRL3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:134,127,406...134,128,733
Ensembl chr 4:134,127,406...134,128,789
|
|
G |
Sh3bp5 |
SH3-domain binding protein 5 (BTK-associated) |
increases expression |
ISO |
Buspirone results in increased expression of SH3BP5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:31,372,614...31,436,100
Ensembl chr14:31,359,880...31,436,078
|
|
G |
Shmt2 |
serine hydroxymethyltransferase 2 (mitochondrial) |
decreases expression |
ISO |
Buspirone results in decreased expression of SHMT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:127,517,123...127,522,444
Ensembl chr10:127,517,123...127,522,444
|
|
G |
Sidt2 |
SID1 transmembrane family, member 2 |
increases expression |
ISO |
Buspirone results in increased expression of SIDT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:45,937,857...45,958,000
Ensembl chr 9:45,937,857...45,955,258
|
|
G |
Sin3b |
transcriptional regulator, SIN3B (yeast) |
increases expression |
ISO |
Buspirone results in increased expression of SIN3B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:72,723,270...72,758,203
Ensembl chr 8:72,723,285...72,758,201
|
|
G |
Sirt5 |
sirtuin 5 |
decreases expression |
ISO |
Buspirone results in decreased expression of SIRT5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:43,365,389...43,395,203
Ensembl chr13:43,365,496...43,395,203
|
|
G |
Slc17a3 |
solute carrier family 17 (sodium phosphate), member 3 |
decreases expression |
ISO |
Buspirone results in decreased expression of SLC17A3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:23,836,922...23,860,718
Ensembl chr13:23,839,434...23,860,716
|
|
G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
multiple interactions |
ISO |
Buspirone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr17:12,584,189...12,628,489
Ensembl chr17:12,584,132...12,628,488
|
|
G |
Slc25a17 |
solute carrier family 25 (mitochondrial carrier, peroxisomal membrane protein), member 17 |
increases expression |
ISO |
Buspirone results in increased expression of SLC25A17 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:81,318,921...81,360,765
Ensembl chr15:81,318,911...81,360,812
|
|
G |
Slc25a20 |
solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20 |
increases expression |
ISO |
Buspirone results in increased expression of SLC25A20 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:108,662,136...108,684,642
Ensembl chr 9:108,662,088...108,684,641
|
|
G |
Slc25a22 |
solute carrier family 25 (mitochondrial carrier, glutamate), member 22 |
increases expression |
ISO |
Buspirone results in increased expression of SLC25A22 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:141,429,749...141,437,874
Ensembl chr 7:141,429,744...141,437,892
|
|
G |
Slc26a8 |
solute carrier family 26, member 8 |
increases expression |
ISO |
Buspirone results in increased expression of SLC26A8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:28,637,779...28,691,273
Ensembl chr17:28,637,783...28,690,233
|
|
G |
Slc27a5 |
solute carrier family 27 (fatty acid transporter), member 5 |
increases expression |
ISO |
Buspirone results in increased expression of SLC27A5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:12,988,346...12,998,192
Ensembl chr 7:12,988,346...12,998,192
|
|
G |
Slc28a2 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of SLC28A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:122,426,357...122,461,152
Ensembl chr 2:122,426,477...122,461,137
|
|
G |
Slc34a1 |
solute carrier family 34 (sodium phosphate), member 1 |
increases expression |
ISO |
Buspirone results in increased expression of SLC34A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:55,399,622...55,414,695
Ensembl chr13:55,398,187...55,415,592
|
|
G |
Slc34a2 |
solute carrier family 34 (sodium phosphate), member 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of SLC34A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:53,049,353...53,071,664
Ensembl chr 5:53,038,081...53,071,664
|
|
G |
Slc35b4 |
solute carrier family 35, member B4 |
decreases expression |
ISO |
Buspirone results in decreased expression of SLC35B4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:34,155,872...34,177,054
Ensembl chr 6:34,153,380...34,177,111
|
|
G |
Slc37a4 |
solute carrier family 37 (glucose-6-phosphate transporter), member 4 |
increases expression |
ISO |
Buspirone results in increased expression of SLC37A4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:44,396,946...44,402,966
Ensembl chr 9:44,396,852...44,402,968
|
|
G |
Slc41a2 |
solute carrier family 41, member 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of SLC41A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:83,230,848...83,338,037
Ensembl chr10:83,230,848...83,337,882
|
|
G |
Slc49a4 |
solute carrier family 49 member 4 |
increases expression |
ISO |
Buspirone results in increased expression of SLC49A4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:35,694,062...35,769,370
Ensembl chr16:35,694,062...35,769,356
|
|
G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
increases expression |
ISO |
Buspirone results in increased expression of SLCO1A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:141,805,438...141,856,284
Ensembl chr 6:141,805,440...141,856,199
|
|
G |
Slfn3 |
schlafen 3 |
decreases expression |
ISO |
Buspirone results in decreased expression of SLFN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:83,191,330...83,215,154
Ensembl chr11:83,191,330...83,215,154
|
|
G |
Smim26 |
small integral membrane protein 26 |
increases expression |
ISO |
Buspirone results in increased expression of SMIM26 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:144,594,065...144,595,366
Ensembl chr 2:144,594,054...144,595,366
|
|
G |
Smoc1 |
SPARC related modular calcium binding 1 |
increases expression |
ISO |
Buspirone results in increased expression of SMOC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:81,026,808...81,186,414
Ensembl chr12:81,026,808...81,186,414
|
|
G |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of SND1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:28,480,337...28,935,162
Ensembl chr 6:28,475,139...28,935,162
|
|
G |
Snrnp25 |
small nuclear ribonucleoprotein 25 (U11/U12) |
increases expression |
ISO |
Buspirone results in increased expression of SNRNP25 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:32,205,415...32,208,996
Ensembl chr11:32,205,415...32,208,984
|
|
G |
Sod3 |
superoxide dismutase 3, extracellular |
decreases expression |
ISO |
Buspirone results in decreased expression of SOD3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:52,363,804...52,369,738
Ensembl chr 5:52,363,791...52,371,418
|
|
G |
Sparc |
secreted acidic cysteine rich glycoprotein |
decreases expression |
ISO |
Buspirone results in decreased expression of SPARC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:55,394,159...55,420,080
Ensembl chr11:55,394,500...55,423,183
|
|
G |
Spcs2 |
signal peptidase complex subunit 2 homolog (S. cerevisiae) |
decreases expression |
ISO |
Buspirone results in decreased expression of SPCS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:99,837,569...99,870,340
Ensembl chr 7:99,837,569...99,863,462
|
|
G |
Spg20 |
spastic paraplegia 20, spartin (Troyer syndrome) homolog (human) |
decreases expression |
ISO |
Buspirone results in decreased expression of SPG20 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:55,112,108...55,137,332
Ensembl chr 3:55,112,108...55,137,322
|
|
G |
Spg21 |
SPG21, maspardin |
increases expression |
ISO |
Buspirone results in increased expression of SPG21 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:65,453,289...65,488,470
Ensembl chr 9:65,460,947...65,488,470
|
|
G |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
increases expression |
ISO |
Buspirone results in increased expression of SPINK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:43,728,069...43,737,237
Ensembl chr18:43,728,082...43,737,557
|
|
G |
Spns1 |
spinster homolog 1 |
increases expression |
ISO |
Buspirone results in increased expression of SPNS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:126,370,060...126,377,934
Ensembl chr 7:126,370,060...126,377,450
|
|
G |
Sptssa |
serine palmitoyltransferase, small subunit A |
increases expression |
ISO |
Buspirone results in increased expression of SPTSSA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:54,645,374...54,656,572
Ensembl chr12:54,645,392...54,656,573
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of SREBF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:60,199,084...60,224,186
Ensembl chr11:60,199,089...60,222,581
|
|
G |
Srgn |
serglycin |
decreases expression |
ISO |
Buspirone results in decreased expression of SRGN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:62,493,833...62,527,445
Ensembl chr10:62,493,833...62,527,451
|
|
G |
Srp72 |
signal recognition particle 72 |
decreases expression |
ISO |
Buspirone results in decreased expression of SRP72 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:76,974,701...76,999,935
Ensembl chr 5:76,974,683...76,999,937
|
|
G |
Srpr |
signal recognition particle receptor ('docking protein') |
decreases expression |
ISO |
Buspirone results in decreased expression of SRPR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:35,211,203...35,217,003
Ensembl chr 9:35,200,175...35,247,973
|
|
G |
Srprb |
signal recognition particle receptor, B subunit |
decreases expression |
ISO |
Buspirone results in decreased expression of SRPRB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:103,188,033...103,202,065
Ensembl chr 9:103,188,032...103,202,137
|
|
G |
Srrm2 |
serine/arginine repetitive matrix 2 |
increases expression |
ISO |
Buspirone results in increased expression of SRRM2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:23,790,527...23,824,741
Ensembl chr17:23,790,532...23,824,741
|
|
G |
Srsf2 |
serine and arginine-rich splicing factor 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of SRSF2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:116,849,897...116,853,675
Ensembl chr11:116,849,901...116,853,094
|
|
G |
Srsf3 |
serine and arginine-rich splicing factor 3 |
decreases expression |
ISO |
Buspirone results in decreased expression of SRSF3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:29,032,660...29,043,372
Ensembl chr17:29,032,628...29,043,373
|
|
G |
Srsf4 |
serine and arginine-rich splicing factor 4 |
increases expression |
ISO |
Buspirone results in increased expression of SRSF4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:131,873,530...131,901,725
Ensembl chr 4:131,873,617...131,901,706
|
|
G |
Ssr1 |
signal sequence receptor, alpha |
decreases expression |
ISO |
Buspirone results in decreased expression of SSR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:37,971,401...37,994,208
Ensembl chr13:37,966,605...37,994,217
|
|
G |
Ssx2ip |
synovial sarcoma, X 2 interacting protein |
decreases expression |
ISO |
Buspirone results in decreased expression of SSX2IP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:146,404,642...146,440,144
Ensembl chr 3:146,404,642...146,440,144
|
|
G |
St6gal1 |
beta galactoside alpha 2,6 sialyltransferase 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of ST6GAL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:23,224,729...23,360,350
Ensembl chr16:23,224,740...23,360,350
|
|
G |
Stac3 |
SH3 and cysteine rich domain 3 |
decreases expression |
ISO |
Buspirone results in decreased expression of STAC3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:127,501,617...127,508,823
Ensembl chr10:127,501,686...127,508,823
|
|
G |
Stap2 |
signal transducing adaptor family member 2 |
increases expression |
ISO |
Buspirone results in increased expression of STAP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:55,997,074...56,008,402
Ensembl chr17:55,997,077...56,005,584
|
|
G |
Stard5 |
StAR-related lipid transfer (START) domain containing 5 |
decreases expression |
ISO |
Buspirone results in decreased expression of STARD5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:83,632,017...83,642,328
Ensembl chr 7:83,631,959...83,653,127
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of STAT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:52,119,438...52,161,865
Ensembl chr 1:52,119,440...52,161,865
|
|
G |
Stbd1 |
starch binding domain 1 |
increases expression |
ISO |
Buspirone results in increased expression of STBD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:92,603,051...92,606,579
Ensembl chr 5:92,603,041...92,606,579
|
|
G |
Steap3 |
STEAP family member 3 |
decreases expression |
ISO |
Buspirone results in decreased expression of STEAP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:120,226,414...120,271,081
Ensembl chr 1:120,190,757...120,272,705
|
|
G |
Stmn1 |
stathmin 1 |
decreases expression |
ISO |
Buspirone results in decreased expression of STMN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:134,468,320...134,473,843
Ensembl chr 4:134,468,320...134,473,843
|
|
G |
Sumo3 |
small ubiquitin-like modifier 3 |
decreases expression |
ISO |
Buspirone results in decreased expression of SUMO3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:77,606,097...77,618,331
Ensembl chr10:77,606,097...77,618,331
|
|
G |
Sun2 |
Sad1 and UNC84 domain containing 2 |
increases expression |
ISO |
Buspirone results in increased expression of SUN2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:79,724,068...79,742,536
Ensembl chr15:79,724,070...79,742,536
|
|
G |
Svip |
small VCP/p97-interacting protein |
increases expression |
ISO |
Buspirone results in increased expression of SVIP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:51,997,161...52,006,018
Ensembl chr 7:51,997,171...52,006,018
|
|
G |
Tagln2 |
transgelin 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of TAGLN2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:172,500,246...172,507,375
Ensembl chr 1:172,500,047...172,507,380
|
|
G |
Tars |
threonyl-tRNA synthetase |
decreases expression |
ISO |
Buspirone results in decreased expression of TARS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:11,383,663...11,399,658
Ensembl chr15:11,382,301...11,399,665
|
|
G |
Tcerg1 |
transcription elongation regulator 1 (CA150) |
decreases expression |
ISO |
Buspirone results in decreased expression of TCERG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:42,511,304...42,575,785
Ensembl chr18:42,511,487...42,575,793
|
|
G |
Tcirg1 |
T cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein A3 |
decreases expression |
ISO |
Buspirone results in decreased expression of TCIRG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:3,896,050...3,907,133
Ensembl chr19:3,896,050...3,907,133
|
|
G |
Tcta |
T cell leukemia translocation altered gene |
increases expression |
ISO |
Buspirone results in increased expression of TCTA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:108,302,955...108,306,159
Ensembl chr 9:108,302,958...108,306,160
|
|
G |
Tdo2 |
tryptophan 2,3-dioxygenase |
increases expression |
ISO |
Buspirone results in increased expression of TDO2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:81,958,412...81,975,728
Ensembl chr 3:81,957,090...81,976,202
|
|
G |
Tef |
thyrotroph embryonic factor |
increases expression |
ISO |
Buspirone results in increased expression of TEF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:81,802,673...81,826,863
Ensembl chr15:81,802,421...81,826,863
|
|
G |
Tent2 |
terminal nucleotidyltransferase 2 |
decreases expression |
ISO |
Buspirone results in decreased expression of TENT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:93,145,855...93,192,435
Ensembl chr13:93,146,282...93,192,385
|
|
G |
Tex264 |
testis expressed gene 264 |
increases expression |
ISO |
Buspirone results in increased expression of TEX264 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:106,658,746...106,685,952
Ensembl chr 9:106,658,746...106,685,927
|
|
G |
Tfg |
Trk-fused gene |
decreases expression |
ISO |
Buspirone results in decreased expression of TFG mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:56,690,329...56,717,467
Ensembl chr16:56,690,332...56,717,450
|
|
G |
Tgm2 |
transglutaminase 2, C polypeptide |
decreases expression |
ISO |
Buspirone results in decreased expression of TGM2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:158,116,405...158,146,392
Ensembl chr 2:158,116,402...158,146,436
|
|
G |
Thrsp |
thyroid hormone responsive |
decreases expression |
ISO |
Buspirone results in decreased expression of THRSP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:97,412,933...97,417,550
Ensembl chr 7:97,412,938...97,417,730
|
|
G |
Timm10b |
translocase of inner mitochondrial membrane 10B |
increases expression |
ISO |
Buspirone results in increased expression of TIMM10B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:105,640,445...105,655,748
Ensembl chr 7:105,640,056...105,643,637 Ensembl chr 7:105,640,056...105,643,637
|
|
G |
Tkfc |
triokinase, FMN cyclase |
decreases expression |
ISO |
Buspirone results in decreased expression of TKFC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:10,592,197...10,605,482
Ensembl chr19:10,587,791...10,605,654
|
|
G |
Tkt |
transketolase |
decreases expression |
ISO |
Buspirone results in decreased expression of TKT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:30,549,131...30,574,724
Ensembl chr14:30,548,359...30,574,720
|
|
G |
Tle1 |
transducin-like enhancer of split 1 |
increases expression |
ISO |
Buspirone results in increased expression of TLE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:72,109,945...72,200,989
Ensembl chr 4:72,117,142...72,200,919
|
|
G |
Tm2d2 |
TM2 domain containing 2 |
increases expression |
ISO |
Buspirone results in increased expression of TM2D2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:25,017,211...25,023,260
Ensembl chr 8:25,017,211...25,023,260
|
|
G |
Tm2d3 |
TM2 domain containing 3 |
increases expression |
ISO |
Buspirone results in increased expression of TM2D3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:65,693,417...65,701,913
Ensembl chr 7:65,691,169...65,701,913
|
|
G |
Tmed9 |
transmembrane p24 trafficking protein 9 |
decreases expression |
ISO |
Buspirone results in decreased expression of TMED9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:55,593,135...55,597,697
Ensembl chr13:55,573,732...55,597,697
|
|
G |
Tmem106b |
transmembrane protein 106B |
increases expression |
ISO |
Buspirone results in increased expression of TMEM106B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:13,069,759...13,089,269
Ensembl chr 6:13,069,759...13,089,269
|
|
G |
Tmem14c |
transmembrane protein 14C |
increases expression |
ISO |
Buspirone results in increased expression of TMEM14C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:41,016,250...41,022,582
Ensembl chr13:41,016,292...41,022,586
|
|
G |
Tmem203 |
transmembrane protein 203 |
increases expression |
ISO |
Buspirone results in increased expression of TMEM203 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:25,255,439...25,256,352
Ensembl chr 2:25,255,439...25,256,292
|
|
G |
Tmem205 |
transmembrane protein 205 |
increases expression |
ISO |
Buspirone results in increased expression of TMEM205 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:21,921,009...21,927,535
Ensembl chr 9:21,921,008...21,927,556
|
|
G |
Tmem214 |
transmembrane protein 214 |
decreases expression |
ISO |
Buspirone results in decreased expression of TMEM214 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:30,869,579...30,877,469
Ensembl chr 5:30,868,012...30,879,180
|
|
G |
Tmem250-ps |
transmembrane protein 250, pseudogene |
increases expression |
ISO |
Buspirone results in increased expression of TMEM250 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:26,136,807...26,140,506
Ensembl chr | |